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Type 2 Diabetes (T2D) has been steadily rising in the United States.  The 
condition is characterized by elevated blood glucose levels and is preceded by insulin 
resistance. Before the onset of T2D patients go through a state of pre-diabetes. To be 
tested for pre-diabetes and diabetes, either a Fasting Plasma Glucose test or an Oral 
Glucose Tolerance Test may be used. While an estimated 24 million Americans have 
T2D, another 57 million Americans are estimated to be in a state of pre-diabetes. There 
are many risk factors that may contribute to the development of T2D including obesity, a 
high calorie diet, lack of physical activity, genetic factors and aging. The complications 
associated with T2D may affect the kidney, nerves, eyes and feet. The prevalence of T2D 
continues to increase in the US and around the world including the developing world. 
Lifestyle interventions have been shown to be an effective way of treating and delying 
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Type 2 Diabetes (T2D) is one of the major causes of death in the United States.
The Centers for Disease Control and Prevention (CDC) has estimated that 8% of the US 
population or about 24 million Americans are living with diabetes. Another 57 million 
people are estimated to have pre-diabetes, and the total prevalence continues to incrase
(1). By 2004 there were 1.3 million new cases of diabetes occurring annually in the 
United States, and in 2007 the number of cases had risen to 1.6 million (2). 
T2D is characterized by the body’s inability to adequately manage blood glucose evels. 
T2D is usually preceded by insulin resistance which may indicate the initial stages of 
elevated blood glucose, progressing to pre-diabetes and eventually to diabetes. Along 
with insulin resistance, T2D may also be caused by genetic, environmental factors and 
cell dysfunction (3). The two environmental factors that have been identified as 
contributing the most to the development of T2D are a lack of physical activity and 
unhealthy eating habits (4, 5, 6, 7, 8). The prevalence and the increasing rise in the 
incidence of T2D, along with the factors potentially causing this disease, call for 







Diabetes versus Pre-diabetes 
Definitions 
Normal blood glucose levels are defined as fasting plasma glucose (FPG) <100 
mg/dL. The hallmark of T2D is hyperglycemia which is defined as abnormally high 
levels of blood glucose of >125 mg/dL using the FPG test. Before the onset of T2D, the 
body goes through a period of elevated blood glucose termed “pre-diabetes”. Pre-diabet s 
is a condition defined by impaired glucose tolerance (IGT) or impaired fasting glucose 
(IFG) (7, 57). IGT is defined as a two-hour blood glucose levels (2h PG) of 140-199 
mg/dL (7.8-11.0 mM/L) using the 75-g oral glucose tolerance test (OGTT), and IFG is 
defined as glucose levels (FPG) of 100-125 mg/dL (5.6- 6.9 mM/L) after an 8 hour fast 
(7, 9, 10).  
The OGTT which measures IGT is a tool that is used to identify people who are at 
a greater risk of developing diabetes (10). Schwartz reported in 2007 that the 
development of diabetes and IGT could be predicted by impaired fasting glucose (11). 
The utilization of both FPG and the OGTT has been instrumental in identifying 
individuals who are at risk for diabetes. The FPG is quick and convenient while the 
OGTT takes more time and is expensive, however, there remain questions about which 
test is best used at various time in diagnosing T2D (10). Health professionals wuld like 
to identify more easily people who are at risk of developing T2D so that they may be 
provided useful education and interventions. One of the problems with diagnosis is that 
most people do not know when to get tested or what the risk factors are for pre-diabetes 
and diabetes. Individuals with IGT or IFG do not show any symptoms nor have scientists 
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associated pre-diabetes with any known disabilities, conditions or specific biomarkers 
(10). Perhaps the best early intervention would be to test people who have at least one 
diabetes risk factor so that they will know their glucose level. 
Many researchers have proposed that health professionals explore all avenues to 
enable them to determine the specific blood glucose levels at which to start lifestyle 
intervention for pre-diabetics (11, 12, 13). It would be ideal to keep the blood levels at 
the normal range and avoid the development of hyperglycemia. The ability to iden ify 
and treat people who are developing these early signs of diabetes could be a good starting 
point in the quest to reverse the current upward trend of diabetes rates. To be successful 
in combating the current surge of T2D cases, it is imperative to understand the 
progression of pre-diabetes to diabetes (12).  
Regulation of Blood Glucose Levels 
Blood glucose levels are regulated by a negative feedback loop. Insulin and 
glucagon are hormones produced by pancreatic cells. When the body is functioning 
normally, insulin is released from the pancreatic β-cells into the blood in response to 
increased levels of blood glucose. This generally happens after consuming food. The 
glucose transporters help to usher glucose into the cells when blood glucose levels are 
elevated and to the skeletal muscle for storage and fat cells for use, lowering blood 
glucose levels. Glucose enters the liver by facilitated diffusion independent of insulin. 
Sodium/glucose co-transporter (SGLT) use an symport Na+/glucose mechanism to move 
glucose against a concentration gradient into the intestinal and kidney cells. Glucagon, 
produced by the pancreatic alpha cells helps raise blood glucose levels. It stimulates 
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glycogen catabolism in the liver when the blood glucose levels are low. Glucagon also 
signals the liver to become active in gluconeogenesis and decrease its glycolytic a tivity. 
It also signals the pancreas to stop insulin production when blood glucose levels increase. 
This negative feedback loop helps maintain blood glucose homeostasis. Because they 
lack the enzyme glucose 6 phosphatase, the muscles do not directly contribute to blood 
glucose (although lactate produced in white muscle can be converted to glucose via the 
Cori Cycle in the liver). 
Etiology of Type 2 Diabetes 
Insulin Resistance 
Insulin resistance can be defined as a condition in which the body fails to properly 
respond to insulin. This may be due to insulin deficiency, or the body’s inability to use 
the available insulin. With insulin resistance, glucose concentration increases due to 
glucose appearance exceeding glucose disappearance in the blood. Insulin concentration 
will be increased simultaneously with the blood glucose concentration. When this 
happens the cells will fail to respond to the available insulin and the pancreas will 
produce more insulin because of the elevated blood glucose levels. However, sometimes 
the pancreas is not able to produce adequate insulin to compensate for the increasing 
insulin “resistance” and this may be a result of β-cells’ exhaustion (progressive decline in 
β-cells’ function) (14). Insulin resistance may be a result of the reduction in the numbers 
of insulin receptors, the affinity of the receptors or their diminishing function (15). This 
may be a result of genetic predisposition or aging. Insulin resistance can develop 
simultaneously with elevated blood glucose levels or it may occur independently. This 
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negative feedback loop will not help if insulin receptors are decreased in number or 
defective. Glucagon production may be inhibited by the high levels of insulin in the 
blood. Blood glucose will continue to increase and may be at much higher levels than 
normal. Over a period of time this will eventually lead to sustained elevated serum 
glucose levels, termed hyperglycemia. Over time, the elevated levelsof glucose in the 
blood and the inability of the body to clear glucose fast enough from the blood, may 
result in pre-diabetes and eventually T2D (16). 
Obesity and Fat Distribution 
There is an increase in the prevalence of diabetes, pre-diabetes, and obesity in the 
adult population (17, 18). While previously thought to be adult onset diabetes, according 
to the ADA, T2D is now diagnosed in >40% of all adolescence diabetes cases in certain 
parts of the US (18, 19). This is of enough concern to call for a major policy change to 
avoid a public health catastrophe (17, 20). The National Health and Nutrition 
Examination Survey (NHANES) estimated the adult obesity rates at 33.8% (21). Several 
studies have reported that 85-90% of people who have T2D are usually overweight or 
obese (22, 23, 24, 25, 26). Individuals whose Body Mass Index (BMI) range from 25-
29.9 are said to be overweight, while those with a BMI of over 30 are considered to be 
obese. BMI is an indicator of body fat based on an individual’s height and weight.  
Obesity will often precede insulin resistance and eventually T2D. However, 
overweight or obese people who do not have high amounts of intra-abdominal fat may be 
able to remain in the state of insulin resistance with less chance of developing diabetes 
(27). As a result, obesity increases the risk of developing T2D, but is not a guaranteed 
6 
 
risk factor for T2D. Fat distribution plays a role in determining the level of risk that may 
be associated with the development of diabetes. Fat may be distributed viscerally or 
peripherally in the body. Peripheral subcutaneous fat is the fat that is deposited under the 
skin and is mostly well distributed over the body, mostly in the hips, upper arms and 
thighs. Visceral fat is stored in the abdomen and it is thought to have a higher metabolic 
activity level. When visceral fat is accumulated in organs such as the liver and muscle, it 
is likely to impair the function of organs and this may contribute to insulin resistance (28, 
29). This may also be caused by increased lipolysis, along with impaired glucose uptak  
which will lead to elevated free fatty acids. This is also likely to eventually lead to insulin 
resistance. Fatty acids will bind to the cell membranes of non-adipose cells and this will 
result in the impaired function of the tissue. An example of this would be skeletal muscle 
cells which will be less efficient if the free fatty acids bind to their membrane and as a 
result reduce their effectiveness at glucose uptake (30, 31). 
 Nuclear factor κB (NF-κB) is a nuclear transcription factor that regulates DNA 
transcription (32). It is found in the cytoplasm bound by inhibitor protein. NF-κB 
activates gene expression for inflammatory compounds, regulation of cell proliferation 
and apoptosis in response to stimuli such as stress, free radicals, cytokines, lymphokines 
and growth factors (33) and may contribute to incidences of autoimmune disease. Studi s 
have reported that high levels of fat and fatty acids can lead to the activation Jun N-
terminal kinase (JNK), inhibitor of NF-κB kinase (IKK), and novel isoforms of protein 
kinase C in insulin sensitive cells (30, 34, 35) (Fig.1). This could happen in the 
adipocytes, liver and skeletal muscle cells. Once activated, the kinases can l ad to 
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“inflammation and cell adhesion” (30, 36, 37). Individuals whose fat mass is mostly 
distributed as  peripheral subcutaneous fat may have less risk for development of 
diabetes; while fat that is mostly distributed in the abdomen will result in an increased 
risk for diabetes. This is because excessive abdominal fat contributes to the development 
of insulin resistance by releasing high amount of free fatty acids into the blood. High 
levels of lipid accumulated in non adipose tissue is associated with insulin resistance 
(80). This conclusion is consistent with the fact that about 90-95% of all people with 
diabetes have T2D and about 90% of those who have T2D are either overweight or obese 
(24, 25). 
A number of studies have shown that increased subcutaneous abdominal fat or 
increased visceral fat may underlie central adiposity, particularly if the two conditions are 
coexisting (6, 22, 23). However, using a CT scan, Bray and colleagues found that 
subcutaneous fat measured by CT scan did not predict diabetes, and that waist 
circumference was a much better predictor of diabetes risk (22). In an earlier study of 
participants who were in a fat and weight reduction targeted exercise regimen, Carr and 
colleagues found that people who decreased their weight and body fat had better insulin 
sensitivity. They also found that the decrease in “weight and intra-abdominal fat, but not 
percent body fat or abdominal subcutaneous fat, were associated with a 24-month 
positive improvement in β-cell function” (6). The findings from Bray’s study seem to 
suggest that being overweight or obese does not necessarily lead to the development of 
diabetes. The Carr study indicates that intra-abdominal fat could be a more reliable target 
for fat reduction. This information should be borne in mind for understanding the 
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complexities of the disease and when designing interventions that could restore the 




A diet high in calories and saturated fat will likely result in the development of 
obesity, unless the calorie consumption is countered with adequate caloric expenditure. A 
balanced diet is one of the more effective approaches to diabetes prevention and 
treatment. The 2005 Dietary Guidelines for Americans recommends that a person on a 
2000 kcal diet plan should consume a diet composed of 45-65% kcal from carbohydrates, 
20-35% from fat (< 10% saturated fat), and 10-35% of protein (38). The USDA 
MyPyramid recommends that this person should consume at least 2 cups of fruits, 2.5 
cups of vegetables, 6 oz of grains, 5.5 oz of meats and legumes, 3 cups of milk, and 6 
teaspoons of oil each day (39). However, when people are given a choice they seem to 
select foods which are high in saturated fat and low in vegetables, fruits, and whole 
grains. It is possible to consume only foods that are considered to be healthy, and still
become overweight or obese or even develop diabetes. As a result, while it is important 
to consume foods that are high in fiber and whole grain, the total amount of calories 
consumed also needs to be considered (40). In a Finnish study (n = 4,344) of dietary 
patterns, participants aged 40-69 consumed a diet high in vegetables and fruits or one 
high in butter, potatoes, and whole milk (79). Researchers found those participants whose 
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dietary patterns included high amount of fruits (185 ± 143 g/day) and vegetables (180 ± 
85.4 g/day) had a lower risk of developing diabetes. In the study of Schulze et al. 35, 
340 participants aged 30–55 yrs whose self- reported dietary patterns were high in refined 
grains, sweetened drinks and processed meat had a higher risk of developing diabetes
associated inflammation (41). Dietary patterns with high vegetable and fruit consumption 
can be clearly associated with a reduction in risk of developing diabetes. 
For people living with diabetes, keeping blood glucose levels as close to normal 
as possible is the major goal. This can be hard to achieve for many patients, and since 
diabetes could be caused by different factors in different people, one approach to lower 
blood glucose may not achieve desired results for all diabetes patients (42). An 
individualized approach is therefore vital for successful diabetes treatment. 
Notwithstanding effects of reducing diabetes due to dietary changes, treating di betes 
with diet is difficult because changing what people eat for the rest of their lives or 
changing the consumption of foods that define their culture is a daunting task (43, 44). 
People may be able to reduce their weight through a weight loss regimen which includes 
lifestyle changes of caloric restriction and physical activity. However, it has been 
reported that most people who lose their weight regain it one year later (40). This may 
help explain the ever-increasing rates of obesity and excess weight which in turn have a 







Along with nutrition, physical activity is a major component of maintaining a 
healthy lifestyle. The CDC defines physical activity as “any bodily movement produced 
by the contraction of skeletal muscle that increases energy expenditure above a basal 
level” (45). Drawing from this definition, it would be wise to state the difference between 
physical activity and exercise because the two terms are sometimes used interchangeably. 
Exercise is a kind of physical activity which is usually designed and structured to 
increase physical fitness (45, 46). There are three components that can be used to as ss 
the level of physical activity or of exercise and these are frequency, intensity and 
duration.  
The frequency of the exercise or physical activity is an important aspect of the 
exercise program. It is important that an exercise reach the objective for which it was 
initially intended, and an exercise program should be performed for the duration of the 
time prescribed. The CDC and the American College of Sports Medicine (ACSM) 
recommend that people should participate in 30 min of moderate physical activity 3-5  
times weekly (45, 46). The intensity of an exercise program can be measured u ing the 
metabolic equivalent (MET), where 1 MET is the rate of energy expenditure whil sitting 
at rest for an hour (47). With this in mind the intensity of an exercise program can be 
defined as being light, moderate or vigorous activity. On a scale of 0-10, low intensity 
requires an energy expenditure of < 3 MET, while 3-5.9 is moderate intensity and 6-8 is 
classified as intense (45).  
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 A number of studies have shown that physical activity along with diet can 
prevent, delay and reduce the risk of developing diabetes (7, 48, 49, 50, 51, 52, 53, 54, 
55). For diabetes management and risk reduction, regulation of blood glucose level 
should be borne in mind in order to achieve the desired blood glucose results. When 
performed at the above mentioned recommended levels of 30 min of moderate physical 
activity for 3 to 5 x/week, physical activity may produce many benefits including 
improvement of carbohydrate metabolism, insulin sensitivity, reducing cardiovascular 
risk, weight loss and weight maintenance, among others (45).  
Genetic Factors 
There is some evidence that fasting plasma glucose is increased when the β-cell 
function is decreased and that this may explain the subsequent increase in IFG for T2D
(56). In individuals who have T2D, elevated blood glucose levels will continue to 
increase, without proper management and treatment (55). Obesity is a major risk factor 
for diabetes; however, if β-cell dysfunction occurs in conjunction with insulin resistance 
there will be an increased risk for an early onset of diabetes (20). If the body has 
declining β-cell function caused by genetic predisposition or other factors such as 
infection that can ultimately lead to low insulin levels, a cascade of events will likely 
occur which will increase the risk of development of T2D (14, 20). It has been reported 
that even after weight loss maintenance, people who are at a high risk of developing 
diabetes are still likely to experience continually declining β-cell function (6). Meyer et 
al. found that β-cell function, as measured by basal insulin release was impaired in 
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individuals who had impaired fasting glucose, but not in individuals with impaired 
glucose tolerance (56).  
 If insulin resistance occurs as the result of the body’s inability to use insulin and 
the β-cells are functioning, then the β-cells may become exhausted due to increased 
insulin demand. This leads to hyperglycemia. After a number of years of having insulin
resistance, the body will eventually progress to pre-diabetes and eventually diabetes (58) 
Stress 
Glucocorticoids increase in response to either physiological or psychological 
stress, but elevated and chronic levels of glucocorticoids will promote the development of 
obesity, particularly visceral obesity, because fat cells in the abdomen are more sensitive 
to cortisol (57). Glucocorticoids may promote insulin resistance by reducing glucose 
production and also reducing glucose uptake in order to preserve the available energy 
(58).  
Family History 
Lyssenko and colleagues reported that a family history of T2D was a major risk 
factor for the development of diabetes. They also indicated that the risk of diabetes was 
not reduced for the second relative of the diabetes patient (5). This is particularly 
disturbing given the report by Cowie and colleagues indicating that about 35.3% of the 







There may be a gender bias to the development and prevalence of diabetes; 
however, different studies have shown variable results (59, 60). Women who gain excess 
weight during pregnancy may increase their chances of developing gestational diabetes. 
Women who have gestational diabetes have a 40% to 60% chance of developing T2D in 
5 to 10 years (61, 81). Gender differences may be influenced by culture. A study of 
Iranian subjects found no significant difference in the prevalence of diabetes on the basis 
of gender (62). However, that country’s national survey found a significant difference in 
the age-related prevalence (P = 0.003) of diabetes for women and men (8.3% vs. 7.1%) 
(17). The 2007 US Diabetes National Fact Sheet indicated 11.2% of men ≥20 years had 
diabetes, while 10.2% of women in this age group had the disease (61). In the US, the 
increased prevalence of diabetes in men (and women) may be influenced by their higher 
prevalence of obesity indicated by a BMI ≥30 (63).  
Age 
Age is a major risk factor for diabetes. The risk of developing diabetes increases 
at age 45, while the majority of people who have T2D are ≥ 55 yrs. (64). This risk usually 
peaks at ages 70-79 in most people (65). There are different reasons why middle aged 
people are more susceptible to developing diabetes. The pancreatic beta cells’ production 
is decreased with age, and middle aged people often lose lean muscle tissue and incre se
adipose tissue. These factors may contribute to insulin resistance and eventually the 
development of diabetes. Ideally, delaying the onset of T2D would reduce complications 
and conditions related to diabetes (5, 7, 8). Additionally, conditions such as retinopathy, 
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high blood pressure and high cholesterol can be delayed or prevented by diabetes 
prevention interventions (44, 54, 66).  
Educational Attainment 
The prevalence of diabetes is highest in those who have <12 years of formal 
education (67). The benefits of modern research, intervention and treatment have 
substantially favored those with <12 years of education (68). This may be due to the fact 
that those with higher educational achievement are more likely to have access to and to 
embrace new technologies. The Danish national dietary survey found that men who had 
<12 years of education consumed less fruit (108±7.8 g/10MJ); and vegetables 
(84±8.4g/10MJ) in comparison with those who had more than 12 years of education, ( 
fruits, (154±11.5g/10MJ); vegetables 126±9.5g/10MJ, P<0.001). (83). A Scottish survey 
found a higher education was associated with a higher health eating score for both men 
(22.6 vs 20.0) and women (25.3 vs 22.2) (84). It was suggested that lack of understanding 
and financial resources may also contribute to these differences. In a review of diabetes 
trends from 1989 – 2005, the prevalence of diabetes among middle-aged participants was 
higher (15.94%) in those with less than a high school education and lower (12.81%) in 
those with more high school (68). This pattern clearly suggests that education was a 
significant factor in diabetes prevalence and possibly for general health. In the same 
study, mortality rates were compared over 16 years. For middle-aged individuals, the 
mortality rate increased (75%) for those with lower levels of education while the rate 
decreased (7%) to (10.37) for those who had at least a college education or more than 12 
years of schooling (68). Educational attainment was clearly an important factor in 
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diabetes care and prevention, and those who had more education were more likely to reap 
the benefits of any available care, intervention and treatment.  
Increasing Prevalence 
Type 2 diabetes is growing at a very fast rate in the U.S. and it continues to have a 
negative economic and public health impact on society (69). The disease has been shown 
also to be an emerging condition of major concern for American children (19). The 
current increasing rate for both adults and adolescents indicates that diabetes will 
continue to be a major cause of concern for the American public in the future (20). 
Banjamin et al. (70) reported that in 2000, about 25% of the overweight adults 
who were between the ages of 44 and 75 had pre-diabetes, i.e., about 12 million adult 
Americans. By 2006, about 35.3% of the adults in the US had diabetes or pre-diabetes, a 
percentage that was equivalent to about 73.3 million Americans (17, 70). The CDC 
National Diabetes Fact Sheet report of 2007 stated that about 23% of the adult population 
over the age of 60 in the U.S. had diabetes (6). The CDC reported the number to be 24 
million by the year 2008. What was also disturbing about this report was that about than 
25% of those who had the disease did not even know about it (1). 
The Southern States 
 While the adult incidence rates of diabetes have increased throughout the U.S., 
the rate of increase has been much higher in the Southern states. In South Carolinathe 
rate of increase for adults was 113% in 2008 when comparing the diabetes rates from 
2005-2007 with those from 1995-1997 (CDC, 2008). In 2010 the prevalence of diabetes 
in South Carolina was 10% compared to 4.9% in 1997 (82). The CDC report showed that 
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of all the states surveyed, South Carolina was second only to West Virginia in the 
prevalence of diabetes (1). 
Worldwide Prevalence 
The increasing diabetes prevalence rate is not limited to the United States: R s 
are increasing in all populations around the world (54). Diabetes affects the developed 
and developing nations (71, 72, 54). Despite years of concern about the problem, not 
enough has been done to avert the continuing trend. In 1997, Pan and colleagues warned 
about the risk of diabetes and that diabetes will be a public burden. They also expressed 
concern that diabetes would lead to vascular complications which may lead to morbidity 
and premature death (72). It is thought that “population growth, aging, urbanization, and 
increasing prevalence of obesity and physical inactivity” are the main contributing factors 
to the increasing diabetes rates (73). Motala and colleagues reported that the peak age for 
diabetes prevalence in South Africa was 55-64 years (71). This age-related prevalence 
was also the case in China where diabetes increased with age and personal annual income 
and was about three times higher than 10 years ago (72, 73). In many countries 
urbanization, obesity and aging may be the major factors behind the increasing di betes 
prevalence. 
Diabetes Complications 
Many studies have documented a strong correlation between diabetes, pre-
diabetes and heart disease and low life expectancy (6, 70, 74, 75). Effective interventions 
could help lessen the risk for all of these conditions (54). Benjamin and colleagues found 
that among individuals who had pre-diabetes, the incidence of CVD risk factors was 
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high: dyslipidemia (94.9%), hypertension (56.5%), smoking (16.6%), and 
microalbuminuria (13.9%) (70). Diabetes takes a toll on the body because it usually 
occurs with many other risk factors such as hypertension, hypertriglyceidemia, low 
HDL-cholesterol, and high concentration of small dense LDL (75). 
The National Institute of Diabetes and Digestive and Kidney Diseases reported 
that diabetes complications affect many organs but most of the damage typically oc urs 
in the kidney, nerves, eyes and feet (76). Diabetic nephropathy occurs when high blood 
glucose causes kidney damage. When the kidneys are damaged their ability to filter 
impurities from the body could be compromised and this may lead to kidney failure (76). 
In diabetes, when high blood glucose causes damage to the nerves it is termed diabetic 
neuropathy. This occurs when the linings of the nerves and blood vessels are damaged 
and may cause diabetic patients to lose feeling in their feet. The glucose tran porter 
(glucose permease) of the red blood cells is not sensitive to insulin and operates meely 
based on blood glucose levels. As a result, when the blood glucose is elevated glucose 
movement into the red blood cells will increase. So the result is increased A1c and all the 
attendant problems which are associated with the statements below. Very high A1c 
reduces efficiency of the Bohr Effect and reduces oxygenation of the tissu s. The blood 
oxygen is reduced due to the defective hemoglobin and its inability to transport oxygen 
effectively. Elevated A1c also reduces nitric oxide transport which leads to failure of 
vasodilation and subsequent increased blood pressure. Damage to the blood vessels (and 
defective hemoglobin) may reduce oxygen to the feet and reduce transport of nitric oxide 
which will adversely affect vasodilation and lead to foot damage and even amputation. 
18 
 
Diabetic retinopathy occurs when the blood vessels of the retina in the eyes are damg . 
This may lead to blurry vision or blindness. Diabetes also increases the risk of having a 
heart attack and stroke and most people with diabetes die from heart attack (69, 70). 
Diabetes and Pre-diabetes Intervention and Prevention 
There is great interest in the medical community regarding how to detect iabetes 
and pre-diabetes in the early stages (77). This is particularly important as the 
development and progression of pre-diabetes to diabetes occurs over many years (58). 
Because pre-diabetes is asymptomatic, patients are not alerted to the prblem and as a 
result, pre-diabetes may go undetected until diabetes actually develops (10, 54).  Another 
problem is that the limited available methods of treatment, such as drug treatment, remain 
inadequate and do not provide a cure, which makes prevention highly desirable (49). 
Preventative intervention seems to be the most viable and reasonable option, and with 
more than 73.3 million Americans who have diabetes or pre-diabetes the need for 
intervention is quite strong (17). A successful intensive intervention for both diabetes nd 
pre-diabetes will be challenging and will not produce the desired results overnight, 
because obesity (as one of the main contributing factors) and diabetes develop over many 
years (58). It is likely that successful interventions require lifelong lifestyle change with 
the additional involvement of local communities and organizations (7). It is inevitable 
that the cost of this kind of intervention will be large and it would be wise to have reliable 
risk and cost assessments prior to embarking on such a large endeavor (75). The cost of 
large intervention studies may be substantially high in monetary and emotional terms; 
however, the expected reduced morbidity and mortality rates linked to the remediation of 
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T2D justify this kind of investment (20). Investing in the community’s health in the form
of accessible intervention and wellness programs will be helpful and rewarding for the 
public and may reduce the public health burden of diabetes (53). 
Many studies have shown that diabetes can be prevented or delayed by lifestyle 
intervention in people who are in a pre-diabetic state, and that reduction in weight and an 
increase in physical activity can decrease the risk of developing diabetes for people who 
have pre-diabetes (8, 53, 54, 56). Some of the more notable diabetes intervention studies 
are the Chinese Da Qing IGT and Diabetes Study, Diabetes Prevention Program, as well 
as the Finnish Diabetes Prevention Study. In the above mentioned studies, researchers 
found that over a period of 3 years or more, there was a reduction in the development of 
diabetes by 42–58% as a result of their lifestyle intervention programs (4, 51, 55, 75). In 
the Finnish study, researchers found that weight loss and increased physical fitness were 
equally correlated to improved glucose tolerance which decreased by –2±12 mg/dL when 
compared to an increase of +0.2±0.8 mg/dL in the control group (P<0.001) (53). 
Individuals who reduced their weight and increased their oxygen uptake attained the best
improvement. This indicated that weight reduction along with physical activity were the 
best interventions when applied together. Additionally Lindstrom and colleagues reported 
that participants had an A1c metabolic improvement of -0.2 ± 0.6 in the treatment group 
compared to an increased A1c in the control group ( 0.06+/ P= 0.002), and that if the 
dietary counseling and resistance training and increased physical activity lifestyle 
changes used in the intervention were continued diabetes could be delayed by several 
years (54). In 2005, Carr and colleagues reported that lifestyle modifications consisting of 
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the American Heart Association (AHA) Step 2 diet and endurance exercise for 24 months 
in Japanese Americans with IGT improved insulin sensitivity, decreased percentage body 
fat, reduced visceral and subcutaneous abdominal fat and increased weight loss (6).  
Interventions may need to be designed differently for different populations and 
locations, taking into consideration cultural and social aspects of each community (53). 
When designing an intervention it would be more cost effective to focus on the 
communities that are more severely affected by obesity and diabetes, thus providing a 
greater initial impact on reducing the prevalence of diabetes in the future (76). It appears 
reasonable to introduce lifestyle interventions to people who are at a higher risk of 
developing diabetes before a diagnosis of pre-diabetes, especially in individuals who are 
obese.  As individuals age, β-cell function decreases and they are more inclined to gain 
weight. This makes long-term lifestyle intervention more difficult (6). It would be a 
challenge for public health professionals to single out obese people to participate in 
interventions because not all obese people develop diabetes (24, 25). 
Those who have pre-diabetes should be given priority for lifestyle interventions as 
they are at a much higher risk of developing diabetes (57). Individuals with IGT may 
reduce T2D risk by implementing lifestyle modifications resulting in improved insulin 
sensitivity, improved β-cell function or both (6). It has been reported that increasing 
regular physical activity and preventing weight gain are essential in order to slow down 
the transition toward the high visceral adipose fat content and high insulin resistance tate 





Diabetes prevalence has continued to increase along with the obesity prevalence. 
There is a need for an effective and feasible solution to curb this prevalence. Public 
health professionals have implemented many strategies to address the obesity epidemic 
including diabetes education and promotion of physical activity and a healthy diet. 
Diabetes interventions involving exercise and diet are more likely the better approach to 
treating and preventing diabetes. However, while most studies including the large-scale 
Da Qing IGT and Diabetes Study, the Diabetes Prevention Program, and the Finnish
Diabetes Prevention and the work of Carr et.al showed insulin sensitivity improved with 
diet and exercise; there have been some conflicting data, with a lesser number of studies 
showing minimal improvement in glucose tolerance and β-cell function (3, 6, 57). Given 
the evidence, it is reasonable to conclude that since current medications have shown little 
or no success in combating the onset and prevalence of diabetes, it would be better to use 
preventative measures. Individuals who have a diagnosis of pre-diabetes and those who 
have diabetes risk factors should be informed of the lifestyle changes that can reduce th  
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Fig. 1 How NF – κB Elicit the Events that Lead to Inflammation Initiated by Fatty Acids 
 
High levels of circulating free fatty acids may activate inflammatory signals. Fatty acids 
and fat activate factors that lead to inflammation through IKK and JNK. Once activated 
IKK and JNK  promote the transcription factor NF - κB, which activate inflammatory 
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DIABETES AND PRE-DIABETES INTERVENTION STUDIES: A REVIEW 
 
 
Type 2 Diabetes (T2D) is one of the major diseases in the world today and the 
prevalence of the disease seems to be increasing at an alarming pace. To combat this 
disease there is a need for lifestyle interventions that could be implemented effici ntly 
and affordably.  Following is a review of lifestyle intervention studies conducte  in the 
US and around the world. The review was used to establish the most effective way of 
implementing a diabetes or pre-diabetes intervention. The majority of the interventions 
focused on T2D interventions and the rest were targeted to those who had pre-diabetes. 
Overall, the risk of developing diabetes was reduced 20% to 58% as a consequence of the 
different lifestyle intervention protocols. 
Introduction 
In this literature review, diabetes and pre-diabetes interventions were assessed to 
determine the most effective treatments. The review was limited to articles published 
from 2000 to 2009. The review search was performed on General OneFile, Expanded 
Academic, Academic OneFile, Academic Search Premier, Medline, and Cinahl Plus. The 
included articles were those which had interventions for diabetes or pre-diabetes s the 
main focal point. The search terms used were “type 2 diabetes interventions”, “impaired 
glucose tolerance”, “impaired fasting glucose tolerance”, and “pre-diabetes 
interventions”.  Articles which focused more on obesity and cardiovascular interve ions 
were included in the review only if the primary focus was on diabetes patients or 
individuals classified as having pre-diabetes.  
33 
 
Participants’ Classifications  
Participants’ blood glucose status was classified as being “normal” for 
participants who had fasting blood glucose levels of <100 mg/dl. Participants were 
classified as having pre-diabetes if their blood values were found to have been at the 
impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) value. The 
classifications were made using one or both of the two blood glucose measuring tests. 
The fasting plasma glucose test (FPG) (6.1-7.0 mM/L or 100 and 125 mg/dl) is 
administered after an overnight or eight hour fast, and the oral glucose tolerance test 
(OGTT) (7.8-11.1 mM/L or 140–199 mg/dl) is used to assess blood glucose levels after 
an overnight fast and also two hours after 75g glucose challenge (1, 2). In US studies, 
researchers either used the ADA levels (Table 2.1) or followed the World Health 
Organizations’ (WHO) (Table 2.2) (3) levels. Studies involving Asians, Asian Americans 
and Native Americans used WHO standards. One study used measurements which 
followed the Japanese Diabetes Society (JDS) recommendations (Table 2.3) (4). 
Analyzed Studies 
There were 28 articles included in the final analysis (Table 2.4). The articles were 
from studies in the US, Mexico, India, Germany, Finland, Canada, Norway, Austria, 
Denmark, Sweden, Israel, Spain, Japan, UK,  Australia and China. Some studies (5, 6) 
were conducted in more than one country. The international scope of this research 
indicates that many countries have realized the importance of finding an effectiv  way of 
responding to increasing global diabetes rates fueled by the obesity epidemic (6, 7). 
Diabetes continues to increase in all countries and among all groups of people, and it is
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expected to continue to increase worldwide (7). It is now well known that individuals 
who have T2D are usually overweight or obese (7). Currently, the diabetes and obesity 
rates continue to increase in all nations and all ethnic groups. It is logical to deduce that 
we have not been able to produce drugs or a message powerful enough to change the 
course of the epidemic or to at least halt its current rate (5, 6, 7). For the current diabetes 
trends to change there is a need for serious fundamental lifestyle changes in America and 
around the world. 
Table 2.4 summarizes the main characteristics from the research articles 
reviewed. The table includes: purpose of the relevant intervention, location or cunt y 
where the intervention took place, sample size, subject blood glucose status at the 
beginning of the intervention (diagnosis), type of intervention used, length of study, and 
some of the key findings. More details about each reviewed study are discussed at the end 
of the table. 
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 Type of Diet Program: 1-Caloric restriction diet, 2-Increase fruits and vegetables,  
 Type of Physical Activity: 1-Weight loss physical activity, 2- Regular physical activity. 
 Type of Exercise: 1-Regular exercise program 2-Moderate intense program.  
 * The average length of participation for all the participants in the study. 





In Tokyo, Japan, Watanabe and colleagues (4) studied working men (n = 173) 
who had pre-diabetes, or were at high risk of developing diabetes. Pre-diabetes was 
diagnosed according to the Japanese Diabetes Society (JDS) standard which defines 1-h 
PG values of ≥10 mM/L as “borderline diabetic” (Table 2.3) (4). The researchers 
developed a new dietary education (NDE) program which included individualized dietary 
counseling. Participants aged 35-70 were randomly divided into two groups: NDE (n = 
86), and controls (n = 87) who received standard care. Patient responses to a 65-item 
semi-quantitative food frequency questionnaire were the basis for prescribing 
individualized diets.  Participants in the treatment group received individualized feedback 
from their questionnaire responses and were counseled on ways they could best improve 
their health by following the recommended guidelines. The counseling session wa 
conducted a month after the health checkup; six months later the second session was 
conducted following another health checkup. The results from the study indicated that an
individualized approach was significantly better than standard care. The interve tion 
group had lower energy consumption in comparison with the controls, and had a 15.3%, 
(P = 0.002) success rate for following the recommended dietary guidelines compared to 
6.0% (P = 0.002) in controls. The intervention group had a decreased 2-h PG after 1 year, 
while the control group increased, the percentage difference between the two groups was 
15.2% (P <0.001) (4).  
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In the Finnish Diabetes Prevention Study (DPS) (8, 9), a diet and exercise 
intervention was shown to reduce the risk of developing diabetes by 58 % (P<0.001) in 
subjects (n = 522) who had pre-diabetes. This ground-breaking, randomized, controlled 
study was one of the first to show that diabetes can be prevented through diet and 
exercise in people who have pre-diabetes (8). In the DPS, subjects were randomly 
assigned to two groups 1) a regular care group (control) or 2) an intensive intervention 
group (treatment). Inclusion criteria were based on the following: (1) age 40-64 yrs at 
screening, (2) BMI >25 kg/m2 at screening and (3) a mean value of two 75-g OGTTs in 
the IGT range based on WHO criteria (8, 9). The treatment group was given the 
following goals: reduce weight by ≥5%; moderate-intensity physical activity for ≥30 min 
every day; reduce dietary fat energy intake to <30% of total energy (E%); reduce 
saturated fat consumption to <10 E%; and increase fiber consumption by ≥15 g/1,000 
kcal (9). At year one, average weight was reduced 4.5±5.0kg (5.1%) in the intervention 
group (n = 256), compared to an average reduction of 1±3.7kg (1.1%) in the control 
group (n = 250) (P<0.0001). At 3 years, results were 3.5±5.1kg (4.0%) for the 
intervention group (n = 231) and 0.9±5.4kg (1.1%) for the control group (n = 203), 
respectively (P<0.0001). BMI for the 1 year period was reduced on average by 1.6 kg/m2
in the intervention group and by 0.4 kg/m2 in the control group (P<0.0001). These results 
were similar at year 3 with BMI reduced 1.3 kg/m2 in the intervention group and 0.3 
kg/m2 in the control group (P<0.0001). There were significant improvements in the 
fasting plasma glucose -0.2±0.7 mg/dL (P <0.0001), 2-h plasma glucose -0.9±1.9 mg/dL 
mg/dL (P<0.001) and the A1c -0.1± 0.7 (P<0.003) in the treatment group (9). It was 
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concluded that the diabetes risk reduction and the improvements in the glucose tolerance 
and body weight were a direct result of the lifestyle intervention (8). It is worth noting 
that the DPS study was suspended because the diabetes incidence was significantly 
(P<0.001) lower in the treatment group than in the control group (8, 9). The DPS and 
Diabetes Prevention Program (DPP) studies showed that people with pre-diabets and 
those at risk of developing diabetes can reduce their risk by 58% through lifestyle 
interventions.  
In a long-term study in Japan, male participants (n = 458) with pre-diabetes w r  
assigned to a standard intervention group (control group) or an intensive intervention 
group (10). The intensive diet and exercise intervention was designed to promote 
attainment of an ideal weight indicated by a BMI ≤ 22 kg/m2 (10). Participants in the 
intensive treatment group were asked about their diet, advised on ways to reduce calori  
intake and maintain their weight, and asked to participate in physical activity or exercise, 
such as walking for 30–40 min per day (10). Control group participants were encouraged 
to exercise and diet to avoid weight gain and to attain a BMI ≤24 kg/m2. At year 4 
diabetes incidence was 9.4% and 3%, standard vs. intensive intervention, respectiv ly, 
(P<0.001) (10). There was a significant difference in weight loss between groups with the 
standard intervention group losing -0.39±1.42 kg and -2.1±1.63 kg in the intensive 
intervention group (P<0.001) (10). The study was effective in reducing the risk of 
developing diabetes. The percentage improvement in impaired glucose tolerance was 
53.8% to normal BG values in the improvement intensive intervention group and 33.9% 
improvement in the control group (P<0.001) (10). 
47 
 
In Australia, Laatikainen and colleagues' Greater Green Triangle (GGT) Diabetes 
Prevention Project (11) included adults aged 40-75 diagnosed with pre-diabetes or at a 
high risk of developing diabetes due to other risk factors. The goal was to determin  if it 
was possible to attain previous results of randomized controlled trials (8, 9, 10) that had 
achieved close to 60% success rate in a primary care facility setting. The GGT trial was 
based on the Finnish DPS study (8). The intervention included six motivational sessions 
of 90 minutes each, with the first five sessions given within the first 3 months and the 
final session given during the eighth month. During these sessions patients were 
encouraged to take charge of their diabetes-related conditions and choose the best ways 
to reduce the risk of developing diabetes through diet and exercise management.  There 
was an average improvement of 4.0% in waist circumference, a weight reduction of 2.7% 
and BMI reduction of 2.8%. This study achieved less robust results than those seen in 
clinical trial interventions; however, it demonstrated that it is possible to achieve a 
successful intervention in a primary care facility (11). 
Absetz and colleagues (12), conducted a study in subjects (n = 352) aged 50–65, 
who had a higher risk of developing T2D (indicated by elevated blood glucose, or lipids, 
obesity and hypertension). Subjects were divided into groups and offered either a 
counseling intervention or diet and exercise intervention to reduce their risk of 
developing diabetes. After 3 years of counseling there were improvements, but the 
counseling group results were less than those seen in the diet and exercise intervention 
group. The intervention was designed to emulate a real life scenario to provide evidence 
that people can do things that may improve their lifestyle and health (12). The study had 
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5 criteria set for the participants to reach by the end of the study: (1) <30% of total energy 
intake from fat; (2) <10% of total energy intake from saturated fat; (3) ≥15 g of 
fiber/1,000 kcal; 4. 4 h/week moderate level physical activity; and (5) >5% weight 
reduction (12). The authors reported that 20% of the participants were able to reach 4 of 
these goals and in addition some of the risk factors, such as diastolic blood pressure, 
weight and waist circumference were reported to have decreased. However, BMI was 
decreased in male participants only. While 71 of the participants were able to improve 
and reach some of the 5 goals set (average = 3) for the study, there were 281 participants 
who did not reach the goals set (12).  
The Diabetes Education & Prevention with a Lifestyle Intervention Offered at the 
YMCA (DEPLOY) study conducted by Ackermann and colleagues (13), evaluated how 
an adapted DPP program would work in a community, or a “real-world” setting (13). The 
researchers wanted to assess how the DPP achievements (8) can be atti ed in a study 
conducted by YMCA staff members. To achieve this goal, YMCA staff members were 
trained to conduct the study utilizing some of the strategies used by professionals in the 
DPP and other similar programs (13). The study paired 92 participants from two YMCA 
facilities; 46 received standard advice on diet and physical activity and the other 46 were 
enrolled in the DPP (17). After 4-6 months there was a reduction in weight of 2.0 % 
(95% CI = 3.3 - 0.6) for the standard advice and 6.0% (95% CI = 7.3 - 4.7) for the DPP 
group (P<0.001) (13). There was also a significant reduction in BMI of 2.3 kg/m2 (95% 
CI = 3.7 - 0.8) and 5.8 kg/m2 (95% CI = 7.3 - 4.4) in control and intervention groups (P = 
0.001). No significant difference in A1c, 0.1 (95% CI = 0.2 - 0.01) occurred at 4-6 
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months for either standard advice or DPP groups (P = 0.96). At 6-12 there were BMI 
changes of 1.4 kg/m2 (95% CI = 3.6 - 0.8) and 6.7 kg/m2 (95% CI = 9.1 - 4.4) (P = 0.002) 
in the standard advice and DPP, respectively. There was no significant change in A1c for 
both groups (P = 0.28) (13). There were fewer significant improvements in DEPLOY 
participants compared to the DPP and similar programs. It may still be more 
advantageous to be enrolled in an intervention run by professionals within a medical or 
academic setting as the improvements are significant. However, this study demonstrated 
that by training employees to conduct interventions and providing more financial 
resources; organizations such as the YMCA can provide additional opportunities for 
community-based lifestyle interventions aimed at decreasing the prevalence of chronic 
metabolic disorders. 
In a 20 year follow up of the participants in the Chinese Da Qing Diabetes 
Prevention study (n = 110,660), Li and colleagues (14) measured the impact of 
participation in a long term intervention to determine if such intervention had longer term 
effects which extended beyond diabetes prevention (14, 15). The participants in the 
original study, aged 25-74, were at risk of developing diabetes, and resided in the Hei
Long Jiang Province of China (14). The intervention, which lasted for 6 years, recruited 
subjects (n = 577) with pre-diabetes from 33 clinics (14, 15). This diet and exercis trial 
was one of the first studies to show that diet and exercise can prevent or delay the onset 
of diabetes in people who have pre-diabetes or who are at risk of developing diabetes.  
The risk of developing diabetes was reduced by 31% in the diet only intervention group, 
46% in the exercise only group, and by 42% in the diet and exercise group (14). After 20 
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years, participants in the diet and exercise intervention group had a risk reduction of 51% 
compared to 43% risk reduction after the 6 year intervention.  At 20 years, diabetes rates 
were 11% in the control group and 7% in the intervention group. Participants in the 
intervention group also spent an average of 3.6 fewer years with diabetes when compared 
to controls (14).  This study showed that participating in a lifestyle intervention program 
was far more beneficial and suggested that beneficial effects could last throughout the 
participant’s life.  
Chiasson and colleagues' Study To Prevent Non-insulin-dependent Diabetes 
Mellitus (STOP-NIDDM) (5) was a double-blind, placebo-controlled randomized study 
conducted in Canada, Germany, Austria, Norway, Denmark, Sweden, Finland, Israel and 
Spain. Subjects with pre-diabetes were recruited from high risk populations defi ed by 
having a BMI of 25 to 40 kg/m2 and being 40 - 70 years old, and patients with an 
immediate relative with diabetes. Eligible patients were randomly assigned to either the 
placebo or the acarbose treatment. Acarbose is a α-glucosidase inhibitor used to treat 
diabetes patients in the US and is used to treat both diabetes and pre-diabetes in some 
European countries. Participants met with a dietician and were encouraged to lose weight, 
maintain a healthy body weight and participate in regular physical activity. Weight 
reduction was modest compared with other pre-diabetes interventions. Average weight 
for subjects in the acarbose group slightly decreased from 87.6±15.2 kg to 87.1±15.3 kg, 
while average weight increased slightly in the control group from 87.0±14.1 kg at 
baseline to 87.3±15.2 kg at 3 years. Diabetes risk reduction was 25% in the acarbose 
study. About a quarter of the patients in this study dropped out due to drug side effects. 
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Half of those dropped out during the first year, and about 31% were from the acarbose 
group compared to 19% from the placebo group. Acarbose increased the reversal of pre-
diabetes to normal glucose state, but the relative risk of developing diabetes was 0.75 
(95% CI = 0.63 - 0.9) (P = 0.0015). This meant 32% of the acarbose group and 42% from 
the placebo group developed diabetes (5). 
Knowler and colleagues' Diabetes Prevention Program Research Group (16, 17) 
included pre-diabetic and non-diabetic subjects (n = 3,234) assigned to 3 different 
intervention groups; 1) received placebo (n = 1082); 2) received 850mg metformin twice 
daily (n = 1073); 3) lifestyle intervention program with goals of ≥7% weight loss and 
≥150 minutes of physical activity/week (n = 1079). Lifestyle group subjects were given a 
training session to help with adherence to diet, exercise and a healthy lifestyle; while 
groups receiving metformin or a placebo had individual 20-30 minute sessions in which 
subjects were asked to eat a healthy diet and increase their physical activity (16). Subjects 
were ≥25 years. Participants reduced energy by 249±27 kcal, 296±23 kcal and 450±26 
kcal in placebo, metformin, and lifestyle groups respectively (P<0.001, all). 
There was a difference in the amount of weight lost by the participants in each 
group;  average weight loss/group was 0.1kg with placebo, 2.1 kg with metformin, and 
5.6 kg with  lifestyle-intervention (P<0.001, all).  Calculated diabetes incidence per group 
was 11.1% with placebo, 7.8% with metformin, and 4.8% with lifestyle intervention (16). 
The diabetes incidence was reduced 58% (95% CI = 48% - 66%) for the lifestyle group 
and 31% (95% CI = 17% - 43%) in the placebo group.  Metformin, with a 31% diabetes 
risk reduction (16, 17), was a very good intervention medication and was more effective 
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than acabose which had a risk reduction of 25% as noted below (21). The study findings 
also indicated that metformin and lifestyle intervention were similar in resto ing normal 
fasting glucose, however, lifestyle was more effective in restoring post load glucose (16). 
Pharmacological intervention may be ideal for some patients, but to gain greater risk 
reduction it would be advisable for people at risk of developing diabetes to use lifestyle 
interventions as the preferred first line of prevention. It must be stated; however, that 
pharmacological intervention may be preferable for patients who are not able to 
participate in moderate and vigorous physical activity. Metformin was shown to have the 
capacity to reduce the fasting plasma glucose by levels close to those of physical activity 
during the entire 3 year period of the intervention: This may be promising for impaired 
fasting glucose reduction in patients who have difficulty walking (17). 
Orchard and colleagues set out to determine the prevalence of metabolic 
syndrome in subjects (n = 3234) with pre-diabetes using participants from the DPP study 
(18).  Participants' risk of metabolic syndrome was reduced by 41% in the lifestyle group 
(P < 0.001) and by 17% in the metformin group (P < 0.03) compared with placebo (18).  
Results from the Indian Diabetes Prevention Program (IDPP) (19) compared the 
effects of diet + exercise to the use of metformin on BMI and A1c. There was a risk 
reduction, measured by blood glucose levels and lifestyle changes, of 26.4% in the drug 
therapy group compared to a 28.5% risk reduction in lifestyle modification interve tion 
(19). The A1c for the control group was 6.2±05, 6.2±06 for the metformin group and 
6.1±05 lifestyle group with 6.2±0.6 for the lifestyle and metformin combined (P>0.05). 
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BMI was 26.3±3.7 for the control group, 25.7±3.3 lifestyle group, 25.6±3.7 for the 
metformin group and 25.6±3.3 for lifestyle and metformin combined (P>0.05) (19). 
Torgerson and colleagues' The Swedish XENical in the prevention of Diabetes in 
Obese Subjects (XENDOS) study was conducted using the diabetes drug orlistat and 
lifestyle intervention to prevent the onset of diabetes (20). Subjects were pre-diabetes 
patients and those with a high risk of developing T2D. The study was conducted over a 4 
year period, was aimed at determining both how effective orlistat was in treating 
metabolic disorders and the safety of the drug (20).  Study participants (n = 3305) were 
randomly assigned to either treatment with orlistat, and the lifestyle changes group (n = 
1,650) or the placebo and lifestyle changes group (n = 1,655). At 4 years, both the 
Orlistat (n = 1640) and the placebo (n = 1637) groups had lost very few subjects. Patients 
in the orlistat intervention had a higher diabetes prevention rate as compared to th  
placebo group. The diabetes rate was 9.0% in the placebo group and 6.2% in the orlistat 
group and this was translated into a 37.3% decrease in the risk of developing diabetes 
with orlistat (P = 0.0032) (20). At one year there was a weight reduction of 10.6 kg in the 
oristat group compared to a mean weight loss of  6.2 kg for the placebo group (P<0.001); 
and 5.8 kg compared to 3.0 kg weight reduction at the end of the study for the orlistat and 
the placebo groups, respectively (P<0.001).  
In a study of 156 pre-diabetic and non-diabetic participants, Thamer and 
colleagues reported that the hormone receptor, peroxisome proliferator-activated receptor 
(PPAR)-δ was a significant factor in how much benefit an individual would gain from a 
lifestyle intervention program (21). Thamer and colleagues had previously demonstrated 
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that a single nucleotide polymorphism in the PPRD gene was corrected to predict how a 
subject would respond to diet and physical activity lifestyle intervention (22). This 
polymorphism to insulin sensitivity and the rate at which skeletal muscle would burn 
fatty acids during an aerobic activity (21, 22). The study included parts of theDPP 
program, including a weight reduction of 7% and an increase of at least 150 min/week in 
physical activity (21). They also recommended that participants reduce their saturated fat 
intake, and increase daily fiber intake and physical activity (21, 22). In the current study 
(n = 156), 27% of subjects had impaired glucose tolerance, and none had diabetes. By the 
end of the study, one subject had developed diabetes, and 123 (79%) had normal glucose 
tolerance. Only 32 (21%) still had impaired glucose tolerance. After nine months of 
physical activity and dietary and lifestyle intervention there were significant 
improvements in insulin sensitivity from 11.8 U/kg at baseline to 13.4 U/kg at follow-up 
(P <0.01). The fasting glucose levels remained the same at 5.2 mM/L (P<0.07) before 
and after the intervention while the 2-h glucose (OGTT) improved from 6.7 to 6.3 mM/L 
(P<0.01). The subjects also had significant improvements in body weight, averaged 86.3 
kg (95% CI = 52.5 - 124.7) at baseline, and had an overall weight reduction to 84.0 kg 
(95% CI = 53.3 - 121.8) (P<0.0001). Another significant improvement was noticed in the 
BMI, which initially was 29.0 kg/m2 (95% CI = 19.4 - 43.5), and by the end of the study 
was reduced to 28.0 kg/m2 (95% CI= 18.6 = 39.4) (P<0.0001). Thamer stated that 
increasing muscle volume and reducing body fat were important for maintaining  
successful and effective lifestyle intervention (21).  
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In the Seidel study, subjects (n = 88) from an underprivileged urban setting with 
diabetes or pre-diabetes were enrolled into a Diabetes Prevention Program. The authors 
tested the hypothesis that a successful group lifestyle balanced intervention for 
individuals with metabolic syndrome could reduce the prevalence of diabetes (23). The 
intervention included attending group classes, choosing healthy foods, reducing fat a d
calorie intake and using a pedometer. The 12-14 week study was comprised of 12 weekly 
sessions. Subjects were given local gym memberships, and provided a pedometer and a 
fat calorie counter. Subjects monitored their food intake and physical activity, and were 
given real time feedback on results of the program. At 3 months (12 weeks), 46.4% 
reported a weight loss of ≥5%, and at 6 months, 66.7% retained the body weight loss. 
Assessment of metabolic syndrome status resulted in ≥1 metabolic syndrome component 
improved in the 30 subjects (43.5 %) who submitted their data for review (23).  
Diabetes Studies 
In Mexico, Bacardı´-Gasco´n et al. conducted a physical activity study of women 
(n = 100) in the migrant working communities (24). Subjects were assigned to the 
uninsured (n = 37) and the insured (n = 63) groups. Participants attended 1 hr exercise 
counseling and were given physical activity leaflets. They also attended a 30 min group 
exercise which included strength training, flexibility and aerobic exercises. Participants 
were then encouraged to exercise 20 min during the week. There were no differences 
between insured (1.53±0.03) and uninsured (1.56±0.04) groups in their levels of 
participation in both outdoor and indoor physical activity (P = 0.5) (24). 
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A study conducted by Kirk and colleagues attempted to devise ways to encourage 
physical activity in T2D patients (n = 70) over a 6 month period. Participants were 
assigned to two groups of 35 each with the treatment group given a physical activity
consultant while the control group had no consultant. The exercise consultant met with 
each participant individually and helped him/her make proper adjustments aimed t 
changing to a more physically active lifestyle (this included 30 min physical activity for 
most days of the week). The adjustment was done in 5 stages of behavior change (pre-
contemplation, contemplation, preparation, action and maintenance). Some of the 
strategies included encouraging participants to increase physical actvity and reduce 
relapse. After 6 months the activity per week was different between the groups (95% CI = 
594,501 - 1,723,539) and (95% CI = -1,786,768 - -491,490) for counted activities per 
week as measured by CSA uniaxial accelerometer (25). Patients in the trea ment group 
had a 7.2x increase or 128 min of moderate activity per week (95% CI = 85.0 - 182.5) 
and a 7.6x increase or a 153 min of moderate activity per week (95% CI = 112.5 - 207.5) 
(25).  
Mayer-Davis and colleagues developed the POWER (Pounds off with 
Empowerment) diabetes intervention study, conducted for 12 months in rural South 
Carolina for low income T2D patients at rural health care centers (26). Subjects had 
diabetes, were aged ≥45 years, and had a BMI of ≥25 Kg/m2. Participants were randomly 
divided into 3 groups: intensive lifestyle intervention, reimbursable-lifestyle intervention, 
or usual care (26). The structure and design of the intervention were influenced by the 
DPP (14) with the aim of attaining ≥10% weight loss by reducing dietary fat intake to 
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<25% of caloric intake and maintaining 150 minutes of moderate physical activity/week.  
The POWER study produced modest results for both men and women at 3 and 6 months 
(P>0.05). There was a gender difference at 12 months; women had a mean weight loss of 
1.5 kg while men had a mean weight loss of 4.7 kg (P = 0.02). The study had a high 
number of African American women and the weight loss in this group was lower than 
that attained in other groups and other intervention studies (7, 14). The researches in the 
POWER study cited reasons participants had given as obstacles to behavioral change, 
which included caring for family members, feeling exhausted and being anxious about 
diabetes (26).  
A study in Canada by Jenkins and colleagues (n = 210) (27) was designed to test 
the effectiveness of a low-glycemic index diet compared to a high-cereal fib r diet in 
controlling blood glucose and cardiovascular disease risk factors. A1c was used as an 
indicator of chronic blood glucose elevation in participants with T2D. Subjects were 
randomly assigned to either the low-glycemic index or high-cereal fiber group. Fiber 
intake was different between the treatment group (low-glycemic index) and the control 
group (high-cereal fiber) group. Fiber increased in the low-glycemic index diet group 
(18.7 g/1000 kcal at week 24) in comparison with the high-cereal fiber diet (15.7 g/1000 
kcal at week 24; P<0.001).  A1c decreased 0.50% (95% CI = –0.61% - –0.39%) with the 
low-glycemic index diet and 0.18% (95% CI = –0.29% - –0.07%) with the high-cereal 
fiber diet. This indicated that those in the low-glycemic index diet had a more positive 
outcome in comparison with those who consumed a high–cereal fiber diet. The reduction 
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of the glycemic index indicated that there was a positive correlation with reducing the 
A1c (r = 0.35, P<0.001) (27).  
The Canadian Trial of Carbohydrates in Diabetes (28) was a 1 year diet-only T2D 
management study conducted by Wolever and colleagues. The study was aimed at 
assessing the effects of carbohydrates on A1c, blood glucose and C-reactive protein 
(CRP) based on the source and amount of carbohydrates consumed (28). Participants (n = 
162), who managed diabetes with diet only, were randomly assigned to a high-
carbohydrate, high-glycemic index (high-GI) diet (n = 52), high-carbohydrate and low-
glycemic-index (low-GI) diet (n = 56), or low-carbohydrate, high-monounsaturated-f t 
(low-CHO) diet (n = 54) (28). Participants were assigned key foods to help adherence to 
the prescribed diet, had help from a dietician, and were allowed to continue taking their 
diabetes medications. At one year, carbohydrate energy contributed 47% for the high-GI, 
52% for the low-GI, and 39% for the low-CHO group (28). The energy from fat was 31% 
for the high-GI, 27% for the low-GI, and 40% for the low-CHO diet group. The GIs for 
the three diet groups were 63, 55, and 59 for the high-GI, low-GI and low-CHO 
respectively (28). The A1c declined at the beginning for the low-GI diet (P=0.084), and 
in the same way fasting plasma glucose declined at the beginning for the low-GI and low-
CHO diet groups. These benefits, however, were erased by the end of the study perio  at 
which time the high-GI diet group had the lowest fasting plasma glucose. With no 
differences between the groups, however, the A1c for both groups combined increased 
from approximately 6.1 at the beginning of the study to approximately 6.3 by the end of 
the study (P<0.0001) (28). There was some weight loss at the beginning in the low-GI 
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diet group and some weight gain towards the end of the study period for the low-CHO 
diet group and both were insignificant (28). There were differences in the effects o  diet 
on CRP between the low-GI group (P = 0.0078) and the high-GI diet group (P<0.05) 
with the CRP of the low-GI group being less than that of the high-GI group. CRP had a 
reduction of >20% which was sustained throughout the study (28). 
In the Improving Control with Activity and Nutrition (ICAN) study (29), Wolf 
and colleagues utilized a case management-based intervention for diabetes patients. The 
randomized controlled study had a registered dietician as case manager for diabetes 
patients. The participants were assigned into two groups, the regular care or the dietician 
case management group. All patients continued to receive their regular care during the 12 
months intervention period. A $350 per person fee was required for diabetes patients 
assigned to receive professional help from a registered dietician. Patients in the regular 
care group were free to join any diabetes or weight management programs. The 
researchers assessed how effectively the dietitian-led intervention would wrk, and how 
economical it would be in a primary care environment compared to the usual care. At 12 
months the intervention group had lost an average of 2.4 kg, while those in the usual care 
group had gained on average 0.6 kg. The intervention group lost 5.5 cm in waist 
circumference while those in the usual care group had only lost 1.4 cm. There was a 
difference, in blood glucose levels, between groups as measured by A1c (P = 0.02). 
Patients who received counseling and education from the dietician had a significantly 




A Canadian study by Ménard et al. assessed whether a multi-therapy intervention 
had an improved effect on fasting plasma glucose levels and A1c concentrations. The 
multidisciplinary team set out to determine whether such benefits would be maintained 
for up to 6 months after the 1 year intervention had been completed (30). T2D patients (n 
=72) with ≥8% A1c concentration were put into either usual care (control group) or into 
the multi-therapy intervention group. Baseline A1c for the intervention group was 
9.1±1.0 and 9.3±1.0 for control group and 7.5±1.0 for the treatment group at 12 months 
compared to 8.61±0.3 for the control group. At the 18 month follow-up, it seemed that 
the benefits of the intervention were diminishing as A1c for the intervention group was 
8.1±1.2 compared to 8.6±1.3 for the controls. At 18 months there were no significant 
difference between groups and most of the benefits attained at 12 months had vanished 
for the intervention group (30). Similar to A1c, the fasting plasma glucose at beginning of 
the study was 10.8±3.5 mM/L for the intervention group and 10.7±3.0 mM/L for the 
control group. At 12 months the intervention group had fasting plasma glucose of 8.2±2.8 
mM/L compared to 9.8±2.7 mM/L for the control group. At 18 months the benefits of the 
intervention were again eroding as the intervention group had 8.7±2.5 mM/L compared to 
9.6 ±3.5 mM/L in the control group (30). 
Corse and associates (31) enrolled 58 diabetes patients in a shared decision-
making model. In this model, patients and their primary care provider together decide the 
best way to improve the patients’ diabetes knowledge and care. Patients attended a 2-hr 
educational session in which patients were helped by their primary care provider in 
setting individual goals and also provided some supportive reading materials. In the 10 
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workshops and sessions, patients were asked to determine what was important to them 
about their conditions, and what would be a priority in easing their conditions. Study 
results were disappointing, perhaps due to small sample size. A1c values (n = 33), 
decreased slightly from 7.94±1.49 to 7.62± 1.92 (P = 0.222). The average body weight (n 
= 38) was 228.21±55.11 lbs. and 225.48±55.09 lbs (P = 0.222), initial and final, 
respectively. Significant improvement in diabetes understanding was observed using a 
Diabetes Attitude Scale of 1-7 (1 = poor; 7 = excellent understanding), pre-inte ve tion 
and post-intervention averages were 4.35±1.46 and 5.42±1.27 (P<.001) (31). However, 
this intervention may not be feasible for some patients as it depends heavily on the 
cooperation of the physician and the ability of the patient to pay for extra services 
needed. For a successful intervention a low income patient may need the financial 
resources to pay for required extra services. As a result, this type of intrve tion may not 
be readily available to the greatest percentage of at-risk subjects.  
West and colleagues (32) used motivational interviewing to encourage female 
subjects (n = 217) with T2D to lose weight and improve their blood glucose levels. 
Participants were assigned to a motivational interviewing or a control group. At 6 months 
the intervention group had a significantly greater mean weight loss (4.7±0.45 kg) when 
compared to control (3.1±0.47 kg) (P=0.01) (32). Participants in the intervention group 
began to regain weigh after 12 months, while the control group began to regain weight 
after 6 months. These results suggest that there may be a need to change the intervention 
every 6 to 12 months to avoid weigh regains. A1c was 8 ±0.1 in the treatment group and 
7.1 ±0.1 for the control group (P = 0.02) at six months, at 18 months A1c was equal 
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between the groups (7.4 ± 0.11). This could imply that the benefits of the intervention 
were too small for the A1c levels to be significantly different between the groups    
A Diabetes Outcome Progression Trial (ADOPT) (n = 4127), developed by Khan 
and colleagues (6), was a large study with participating scientists in 15 countries in 
Europe, the US, and Canada. The collaborative intervention evaluated the efficacy and 
effectiveness of several diabetes drugs. The diabetes dugs rosiglitazone, metformin, and 
glyburide were given to diabetes patients who had not been treated with other diabetes 
drugs. The drugs were thought to have failed if the blood glucose levels were >180 
mg/dL (>10.0 mM/L) after an overnight fast. A positive outcome was a fasting plasma 
glucose level <140 mg/dL (7.8 mM/L) after drug therapy. Diabetes patients were 
randomly assigned to three groups; rosiglitazone (n = 1393), metformin (n = 1397), and 
glyburide (n = 1337).  Participants received the drugs in identical capsules, with dosages 
increasing over time. Using the >180 mg/dL fasting blood glucose standard set as a drug 
theraputic failure, 143 patients in the rosiglitazone group “(2.9 per 100 patient-years)” 
fell in this category and 207 in the metformin group “(4.3 per 100 patient-years)”, while 
311 patients in the glyburide group “(7.5 per 100 patient-years)” were in this category. 
The incidence occurrence measured using the Kaplan–Meier distribution was 15%, 21% 
and 34% for rosiglitazone, metformin, and the glyburide groups, respectively. The 
secondary drug outcome measured a <140 mg/dL fasting plasma glucose progression 
rate. For patients assigned to the rosiglitazone group the rate was 79 of 511 participants. 
Metformin group rate was 127 of 520 with risk reduction of 36% (95% CI = 15 - 52) (P = 
0.002) and the glyburide group was 160 of 480 participants with risk reduction of 62% 
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(95% CI = 51 - 72) (P<0.001). After 4 years of treatment 1456 (40%) patients in the 
rosiglitazone drug group had A1c level of less than 7%, in comparison to 1454 (36%) for 
the  metformin group (P = 0.03) and 1441 for the glyburide group (26%) (P<0.001). A1c 
was significantly different between groups (95% CI = 0.49 to 1.9) (6).  
In the Danish Steno-2 Study (n=160), Gaede and co-workers (33) recruited T2D 
patients with microalbuminuria who were treated for an average of 7.8 years.  
Participants were randomly assigned to either the conventional therapy or the intensive 
therapy.  Study goal for the intervention group was to achieve: A1c <6.5%, <75 mg/dL
(4.5 mM/L) total cholesterol, <150 mg/dL (1.7 mM/L) triglycerides, <130 mm Hg and 
<80 mm Hg for the systolic and diastolic blood pressure respectively (33). Patients in the 
intervention group were given blood pressure treatment drugs and a low dose of aspirin 
(33, 34). At the conclusion of the study changes in BMI were not significant. BMI change 
of males was 0.4±0.4 kg/m2 for conventional therapy and 0.7±0.4 kg/m2 for intensive 
therapy (P=0.61), while females’ change in BMI was 1.3±1.3 kg/m2 for conventional 
therapy and 2.3±1.2 kg/m2 for intensive therapy (P = 0.29) (34). Fasting plasma glucose 
with conventional therapy decreased by 18±11 mg/dL; with intensive therapy it 
decreased by 52±8 mg/dL (P <0.001). A1C with conventional therapy increased by 
0.2±0.3 and decreased 0.5±0.2 in intensive therapy (P <0.001). By the end of the 13.3-
year follow up the two groups (total n = 93) seemed to be similar with regard to both 
clinical and biochemical variables. Of the 160 diabetes patients who started the 
intervention, nine patients in the intervention group died from cardiovascular 
complications compared to 19 patients in the control group (P = 0.03) (34). Unlike the 20 
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year follow up of the Chinese Da Qing Diabetes Prevention study (15), the benefits 
attained through this intervention seem to have been reversed at the 13.3 years follow up. 
There were no significant differences between the groups in regard to physical activity, 
body weight and waist circumferences, but there were some significant differences in fat 
and carbohydrate intake (34). 
Conclusion 
Of the 28 studies reviewed the average length of study was approximately 2 years, 
however the median length of the studies was 1.4 years. In 15 of the studies reviewed, th  
subjects had pre-diabetes, while 12 studies were primarily for diabetes patints nd one 
study had participants who had diabetes or pre-diabetes. This review included studis
utilizing different types of interventions, including 13 using diet, 13 using physical 
activity, 8 using drug interventions and 5 studies using education/counseling. Studies 
conducted for an average length of 1 year showed a large improvement in the heal  
status of participants. The greatest improvements were found in studies which combined 
physical activity and diet interventions (8, 20). Participants in studies lasting more than 
one year showed similar benefits during the first year; however, most of the benefits 
seemed to be reversed after the first year (8, 10, 14). This was the case particularly for 
weight regain.  There may be a need to change the intervention structure every 6 to 12 
months to avoid weigh regains. This could also be achieved by the implementation and 




The Danish Steno-2 Study (33) indicated that it is best to prevent diabetes from 
occurring rather than to wait and treat the disease and as can be seen in the follow up at 
13.3 years the benefits of the intervention seem to have disappeared. Even prescription 
drugs taken resulted in no significant difference in the outcome, with an average of 5.5 
medications in the intervention group and 5.7 in the control group (P = 0.64). The study 
strengthens the case that lifestyle intervention through diet and exercis is the best way to 
delay or prevent the onset of T2D in adults. In the DPP study (16), the metformin group 
had a risk reduction of 31 % compared to 58% in the lifestyle group. This was an 
indication that even though metformin is a powerful diabetes medication, it is better to 
implement lifestyle changes and prevent the onset of the disease. Preventative 
intervention offers the best solution not only for diabetes but also for other related 
metabolic and chronic diseases such as cancer, cardiovascular disease, stroke, etc (14, 18, 
29, 33). 
Lifestyle interventions were shown to improve health and to reduce the diabetes 
risk in all the reviewed studies. Studies were conducted in different countries around the 
world, indicating the global nature of the disease. The Da Qing follow up (14) study 
demonstrated the potential benefits for people who are at risk of developing diabetes to 
participate in interventions as the long term gains of doing so could extend far beyond the 
intervention period. The best improvements and diabetes risk reductions (measured by 
fasting plasma glucose, A1c and BMI) were found in participants who had diabetes risk 
factors and those with pre-diabetes. Those who already had diabetes seemed to have 
minor death risk reduction of 20% in one study (35) vs a 28.5% (19) and 58% (8) 
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diabetes risk reduction for those who did not have diabetes at the beginning of the 
intervention. One study (26) demonstrated that in a multiethnic country such as the 
United States healthcare providers need to be sensitive to the needs of people of different
cultural backgrounds. For studies like this to attain a high success rate, clients’ different 
socioeconomic and cultural needs must be taken into consideration. An individualized 
diet recommendation can be an effective means to encourage people at risk of developing 
diabetes to reduce their levels of blood glucose and delay the onset of diabetes. The 
success of the individualized dietary recommendation used in Japan (4) further supports 
this approach.  In the future it may also be advisable to find ways of addressing some of 
the factors that were reported (26) as being barriers to participating in i tervention 
activities. Thus, a community collaborative effort can reduce the burden on mothers who 
have to be caregivers to multiple family members. Another outcome of this study was 
that increased participation was achieved by providing transportation for some patients, 
while others were given intervention material though teleconference.  If many
participants are faced with the same problems/barriers, it may be beneficial to organize 
them into groups that share similar experiences and in that way they may find a common 
solution to problems.  
To improve the general health of the population it is imperative that blood glucose 
levels are tested regularly and that the appropriate therapies are offered to those who need 
them. It would be beneficial for people who are at high risk of developing diabetes to be 
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Table 2.1 American Diabetes Association criteria for the Diagnosis of Normal 
Blood Glucose Values, Pre-Diabetes and Diabetes 
1. Fasting values are defined as 8 hours with no calori  intake. 
2. The test should use the World Health Organization criteria using a glucose load equivalency of 75 g anhydrous 
glucose dissolved in water. 
3. Test should use a certified National Glycohemoglobin Standardization Program (NGSP) protocol that is s andardized 
to the Diabetes Control and Complications Trial (DCCT) assay. 
4. Random or casual blood glucose values are collected regardless of fasting/fed state or time of day. 
 
        Table 2.2 World Health Organization Definitions and Diagnosis of Diabetes  





Normal  <100 <140 <6 
Pre-diabetes  110 – 125 140 – 199 - 
Diabetes ≥126 ≥200 ≥6.5 
1. Fasting values are defined as 8 hours with no calori  intake. 
2. The test should use the World Health Organization criteria using a glucose load equivalency of 75 g anhydrous 
glucose dissolved in water. 
3. Test should use a certified National Glycohemoglobin Standardization Program (NGSP) protocol that is sandardized 
to the Diabetes Control and Complications Trial (DCCT) assay. 
 
 
Table 2.3 Japanese Diabetes Society Definitions and Diagnosis of Diabetes 
  







1. Fasting values are defined as 8 hours with no calori  intake. 
2. 1-h Plasma Glucose according to theJapanese Diabetes Society (JDS) standard definitions. 
3. The test should use the World Health Organization criteria using a glucose load equivalency of 75 g anhydrous 
glucose dissolved in water. 
4. Test should use a certified National Glycohemoglobin Standardization Program (NGSP) protocol that is s andardized 
















Normal  <100 <140 <6 ≤125  
Pre-diabetes  100 – 125 140 – 199 5.7 – 6.4 - 
Diabetes ≥126 ≥200 ≥6.5 ≥200 









Normal <100 - <140 <6 
 Borderline - ≥180 - - 
Pre-diabetes 110 – 125 - 140 – 199 - 









The purpose of this study was to assess the nutrition-related health behaviors and 
diabetes knowledge of employees at Clemson University who had already shown interest 
in their health status by their participation in the CU4Health program. CU4Health is the 
Clemson University Worksite Wellness Screening Program which is provided to 
Clemson University employees, in partnership with the South Carolina Employee 
Insurance Program. Invitations were sent to the CU4Health participants to take part in 
three online questionnaires: 1) demographic; 2) diabetes knowledge; and 3) food intake 
patterns. The surveys included the Michigan Diabetes Knowledge Test, the Block Food 
Frequency Questionnaire and a demographic questionnaire. The objective was to 
compare the results from the college degree-holding participants and those with l ss than 
a college degree. There were different response rates for the three questionnaires, with 
the Diabetes Knowledge Test receiving the highest number of participants. A to al
number of 50, 46 and 40 participants completed the Diabetes Knowledge Test, the 
Demographic Questionnaire and the Block Food Frequency Questionnaire, respectiv ly. 
There were no differences between the mean responses of those with a college degree and 








According to the American Diabetes Association, 8% of the population of the US has 
diabetes and the total prevalence of diabetes increased 13.5% from 2005 to 2007 (1).  In 
2007, the CDC reported that about 23 percent, or 12.2 million, of those aged 60 and over 
in the U.S. had diabetes. They also estimated that, in this time frame, about 536,000 new 
cases appeared among that age group (2). In 2008, the CDC reported that Type 2 diabet s 
(T2D) had increased 90% since 1997 and that about a third of those with diabetes don't yet 
know they have this dangerous disease (3). In this report, it was stated that South Carolina 
diabetes rates increased by 113%, from 1995-1997 to 2005-2007. Of the 33 states 
surveyed by the CDC for T2D, South Carolina had the second highest prevalence (3). T2D 
affects certain groups more than others. Individuals with close relative who have diabetes, 
those who are older than 45 and obese individuals are at a greater risk of developing 
diabetes (2). Minority groups such as Native Americans, African Americans,and 
HispanicAmericans are disproportionately affected by diabetes (3) 
Pre-diabetes 
People who have pre-diabetes are particularly at risk of developing diabetes. Mor 
than 60 million Americans are estimated to have pre-diabetes, defined by impaired 
glucose tolerance (IGT) or impaired fasting glucose (IFG) (4). According to the ADA, a 
person who has fasting plasma glucose of at least 100 mg/dl (5.6 mM/L) but less than 
126 mg/dl (7.0 mM/L) is classified as pre-diabetic (1). It would be desirable for people at 
high risk of developing diabetes to take early preventative measures so that they may 
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delay the progression of pre-diabetes into T2D (5, 6). However, many people do not get 
treatment until they already have developed the disease and, by that time, the treatm nt 
options for T2D are limited or less effective (7). As there is no cure for diabetes, it is 
important that people are made aware of the complications associated with diabetes 
especially as prevention of the disease is the best option (7, 8). In the process of 
identifying those with pre-diabetes, Benjamin and colleagues predicted that additional 
millions of people with undiagnosed diabetes would be identified as well (9). 
In response to increasing healthcare costs, along with the increasing prevalenc  of 
diabetes, Cousineau et al. initiated a 2008 Online Worksite Nutrition Program from 
which they concluded that both the private and public sectors are aware of the need for 
worksite interventions to prevent chronic metabolic conditions (10). Diabetes is known to 
develop along with other chronic conditions such as cardiovascular disease. It, along with 
another causative factor, obesity, may also contribute to the development of hypertension, 
dyslipidemia and increased need for medical amputation (11, 12, 13, 14). Therefore, there 
are many reasons to work toward prevention for those who are at risk.   
CU4Health 
Clemson University is a public university in Upstate South Carolina that employs 
4,909 people, 50.8% male, 49.2% female (15).   Of these, the majority are Caucasian 
(84.21%), followed by African American (10.21%), Asian (04.01%), Hispanic (1.22%), 
Native American (0.122%) and individuals who listed their race as unknown (0.22%). 
The Clemson University Worksite Screening Program (CU4Health) is an 
employee wellness screening program initiated in 1998 for Clemson University 
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employees at the Joseph F. Sullivan Center, in partnership with the South Carolina 
Employee Insurance Program (16). The CU4Health program is provided at a low cost and 
is available to all the Clemson University employees. The Sullivan Centre health 
professionals, who administer the program, assess health risks in individuals by 
measuring height, weight and other parameters which include blood pressure, blood lipid 
profile, and a blood chemistry profile hemogram (16).  
The CU4Health program uses the Personal Wellness Profile (PWP) provided by 
Wellsource, Inc. (Clackamas, OR) to determine an overall wellness score for each 
participant based on the person’s data, which indicates the general condition of the 
patient’s health. Information from the PWP and a follow-up counseling session are made 
available to each participant (16). The areas that are discussed during the couns ling 
session include the patients’ overall fitness which is based on their “cardiovascular 
endurance, or aerobic fitness, flexibility, strength and BMI” (16). The patients are 
encouraged to exercise regularly and exercise tips are provided for patients who have not 
been exercising regularly (16).  Another area that is discussed is the patient's risk for 
developing heart disease. The score given could be influenced by “smoking, cholesterol, 
blood pressure, exercise, diabetes risk, and the patient’s BMI as well as other bl od tests” 
(16). Each health-related topic is discussed with the patient and appropriate 
recommendations made.  
The nutrition score on the PWP reflects how well the patient follows the food 
guide pyramid, low-fat meals, high-fiber foods, fast food/snacks, and breakfast daily (16). 
Other areas included in the counseling session are substance use, coping with stress, 
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cancer risk, and osteoporosis. The counseling session helps to determine if there are areas 
that need follow-up and what the patient should do to make improvements (16). 
By April 2009, the CU4Health program had 1321 names on file of individuals 
who had enrolled between October 1998 and April 2009. In 2008, an assessment of the 
CU4Health data collected by the Sullivan Centre at Clemson University was undertaken. 
The data of the 1321 patients in the CU4Health program indicated that 322 individuals 
(25.7%) had a BMI ≥30, classified as being obese, while 800 CU4Health patients were 
overweight or obese with a BMI of≥25.  
Subjects and Methods 
Subject Selection 
A review of the CU4Health records revealed that 826 (63%) of CU4Health 
participants were at risk of developing diabetes.  After this review, it was decided that it 
would be better to develop a survey assessment and make it available to the CU4Health 
participants. This would provide an idea as to how many of the 1321 participants who 
had participated in the program at any time from 1998 to 2009, and were still on campus, 
would be willing to participate in a diabetes and wellness-related study. 
Subject Recruitment and Participation 
Of the identified potential participants, 861 had a valid Clemson University email
as of May, 2009; a Sullivan Center employee contacted these CU4Health participants and 
invited them to participate in the study.  Invitations were extended by email. The 
CU4Health participants who responded were asked to participate by filling in 3 survey 
questionnaires. Those who chose to participate were provided a link to the website which 
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provided more information on accessing the questionnaires. Participants were given two 
options for participation: 1) complete the questionnaires and grant access to their
CU4Health clinical data [clinical data included health and diet history plus height, 
weight, BMI, blood pressure, Blood Lipid Profile (cholesterol values and triglycerides); 
and Blood Chemistry Profile including blood glucose (blood sugar) and electrolytes as 
well as demographic information] or 2) complete the 3 questionnaires without giving 
access to the clinical data. 
Questionnaire Selection and Administration 
Questionnaire Determinants 
The questionnaires used were chosen to assess the eating patterns and behaviors 
of CU4health participants, with particular interest in what participants consumed during 
the past year.  The food frequency questionnaire method has been shown to be the most 
effective research method for determining the types of food the participants consumed 
during the past 12 months (17). To achieve this, a validated full length 2005 Block Food 
Frequency Questionnaire (FFQ) (18, 19) was used.  A demographic questionnaire, the 
Michigan Diabetes Knowledge Test (MDKT) and the Block FFQ provided by 
NutritionQuest (Berkley, CA) (an organization that provides nutrition and physical 
activity assessment and behavioral support to many universities and research 







Michigan Diabetes Knowledge Test 
The MDKT is validated to reliably assess diabetes knowledge, and is used 
primarily for those who have diabetes (21). The test, developed by the Michigan Diabetes 
Research Training Center (Ann Arbor, MI), can be administered in a 14 question short 
version which is specific for diabetes patients who do not use insulin or those who have 
T2D, and takes about 15 minutes to complete (21, 22).  
Block Food Frequency Questionnaire 
The Block FFQ, a 110 food-related item questionnaire that was originally 
developed from NHANES 1999-2002 (23) was used. This questionnaire provides nutrient 
and food group data about the foods habitually consumed by the participants (24). The 
electronic version of the 2005 Block FFQ was used, which is estimated to take 30-40 
minutes to complete. It can be self-administered and can minimize variability by 
assessing foods consumed over a year. The electronic version of the Block FFQ was ideal 
for this website-based study.   
Demographic Questionnaire 
The demographic questionnaire was designed by a co-investigator. The questions 
included categories such as gender, age, race, marital status, occupation, and household 







Website Design and Content 
A website was designed for the purpose of administering the on-line surveys 
(Appendix A). The website contained a welcome message and participant instructions. 
An informed consent document and the three online surveys were posted on the website 
which was accessible to CU4Health employees only. The MDKT and demographic 
questionnaires were accessible from the first website and were hosted by Zoomerang 
(available at www.Zoomerang.com). A link, provided at the bottom of the first website, 
opened a second website, which contained instructions for participation in the FFQ. The 
second website provided the username and password required for the FFQ and had a link 
to the NutriQuest 2005 Block FFQ.  
Questionnaire Completion Procedures 
The participants were given a choice to either fill in the questionnaires only, or to 
fill in the questionnaires and also allow access to their CU4Health medical history data 
by the principle investigator and collaborators.  Those who chose the second option were 
provided with a consent form to download, print and complete permitting access to their 
clinical data. Signed consent forms were delivered via Clemson mail or in person to the 
principle investigators. Only individuals with signed consent forms were included in the 
CU4Health medical history data protocol. The protocol for the study and consent form 





Statistical Analysis  
Data were compiled and entered in an Excel 2007 spreadsheet. The analysis was 
performed using SAS 9.13 (SAS Institute, 2001).  Level of education was used as an 
independent variable and dependent variables of interest were compared between 
educational levels. Pearson product-moment correlations were performed for a subset of 
variables at the significance of α=0.05. 
A multiple linear regression analysis was also performed on the demographic 
data, as well as clinical and nutritional variables. The stepwise multiple linear regression 
was used to develop a model for the diabetes knowledge score based on demographic 
variables. A second model which included the clinical variables also was develop d.  
Variables of interest were chosen based on their relationship with the MDKT score. A 
comparison was made for the 25 participants who allowed access to their clinical
CU4Health values and some of the values they reported in the study.
Results 
Questionnaire Completion Results 
Of the 861 emails sent to CU4Health participants to invite them to participate in 
the study, approximately 100 emails were sent back as “Invalid users”, which left about 
760 emails that were assumed to have been received. Of these, three potential participants 
called to inquire about the study and 15 replied by email to get more information on how 
to participate in the study. One participant indicated that she did not want to participate n 
the study. Twenty five participants agreed to have their medical records evaluat d; 
consent forms were obtained from all of these participants. 
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The MDKT had the highest number of participants completing the questionnaire. 
There were a total of 85 visits to the MDKT website. Fifty one (60%) participants 
completed the MDKT; the results from one were not included in the final data set 
because less than half of the questions were answered. From a total of 61 visits to the 
demographic questionnaire, 47 (77.04 %) participants completed the questionnaire. For 
the Block FFQ, there were 46 visits, 40 (86.95%) were completed. Thirty six participan s 
completed the Block questionnaire on the first visit. Six participants who had not fully 
completed their questionnaires were contacted and reminded to complete the 
questionnaire; 4 complied, for a total of 40 completed questionnaires. 
Forty-seven participants completed the Demographic Questionnaire (Appendix 
B); however, 1 subject had <50% completion and was excluded from analysis resulting in 
46 satisfactorily completed questionnaires. 
Demographic Questionnaire Results 
The results from the demographic questionnaire are in Table 3.1. Demographic 
information for CU4Health participants (1998 to 2009) is in Table 3.2. Most of the 
participants in this study were female (80%) compared to 59.4% female in th  
CU4Health program (785/1321). Both of these percentages were higher than the 
percentage of female employees at CU (49.20%) in early 2008 (Table 3.3) (16). 
 The age group most highly represented was 50-59 years (46%) in this study and 
in the CU4Health data (33.8%) (Table 3.4). Most study participants reported they wer  
Caucasian; (84%); the same percentage applied to the CU4Health and CU employe  
population. Only 4% of participants reported that they smoked. Forty five percent of the 
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participants reported they had BMI normal in the study, compared to 39.5% from 
CU4Health data. Fifty-five percent of participants reported being either overweight 
(33%) or obese (22%) (Table 3.1). BMI information in Table 3.1 was calculated from the 
self reported height and weight values from the participants’ in this study. For 
participants who allowed access to their CU4 Health clinical data, 52% had normal BMI, 
26% were overweight and 22% were obese. 
Sixty seven percent of study subjects were married and 22% divorced. CU4Health 
participants who allowed access to their clinical data marital status were; 63.3% married, 
23.3% divorced, 10% widowed and 3.3% single. The highest percentage of the 
participants in the on-line study, 35%, had a graduate degree, and 33% had some college 
education, while 43.3% of the CU4Health participants and 45.7% of all the university 
employees had earned graduate degrees, and 25% of CU4Health participants and 20.4% 
of university employees were college graduates. Of the study partici nts, 28% indicated 
that they had a household income of ≥$80,000 and above while 36.2%, of the CU4Health 
group were at this income level. For university employees, the most common income 
level (41%) was $20,000 - $39, 999 while only 14.9% of employee households belonged 
to the ≥$80, 000 income bracket. For the study group, 46% of the participants lived in a 
2-person household, and there were no persons <18 yrs in 79% of the households, and no 
persons > 65 in 94% of the households. An equal percentage of participants, 39%, lived 
in Pickens and Oconee counties with 59% of the participants reporting that they lived in a 





The mean (±SD) MDKT score, from the 50 participants, was 76.85±15.17 
(P<0.001) with a mode of 85.71. Only 5 participants scored 100, with the five lowest 
scores ≤57.14. Of the 16 questions asked, the HbA1c knowledge item had to lowest 
percentage of correct answers (25%). Question 4, which assessed fat content in food, was 
answered correctly by only 55 % of participants. Sixty percent of participants correctly 
answered question 9 (treatment of low blood sugar), and 61% knew the effects of 
infection on blood glucose (question 11). Sixty two percent of participants answered 
question 5 correctly, which pertained to identifying calorie levels presented in food 
labeling. Ninety two per cent of the participants answered a carbohydrate-rel t d question 
(question 12) correctly and 94% correctly answered the question on foot care. Ninety 
eight percent of the participants were able to identify the correct answer in a 
cardiovascular disease related question (question 13) (Appendix C). 
The Block Food Frequency Questionnaire 
Participants who completed the Block FFQ were Caucasian (87.5%) > African 
American and Hispanic (7.5%, each) > Native Americans (2.5%), with 5% "other". 
Females (77.5%) of average age 53.54± 8.50 and men (22.5%) of average age 
48.44±10.46 participated. The mean for BMI was 27.09±5.85. In a scale of 2-7 (2-
completed HS; 7-Graduate degree), the mean educational attainment was a college 
education. Only two participants reported smoking 6 and 15 cigarettes a day, 
respectively. Approximately 37% reported drinking less alcohol than they used to, and 
65% reported currently trying to lose weight. 
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Health status was reported as excellent (20%), very good (47.5%), good (30%), 
and fair (2.7%). Mean calories consumed were 1780±512.38 kcal. Average caloric 
consumption was: protein 71.71g (36.58%); fat 72.85g (16.01%), and carbohydrates, 
210.89g (47.69 %); sweets (12.60%) and alcohol (3.23%). Average fat sources were; 
saturated fat 22.12±9.1g, monounsaturated fat 28.93±10.52g, and polyunsaturated fat 
16.34±5.80g with 1.73±0.68mg Omega-3 fatty acids and 2.28±1.38mg trans fats.  Daily 
cholesterol intake was 70±97.95mg. The amount of dietary fiber consumed was 
20.623±9.22g. The total amount of sugar consumed was 96.76±42.16g.  
Participants reported that they consumed a relatively healthy diet with lo  total 
calories for both the college educated and those without a college education. The data in 
Table 3.5 indicates that there was no significant difference in caloric intake based on 
level of education. Table 3.6 is composed of data of a comparison of My Pyramid 
recommended diet and the results from this study. Participants in this study consumed, on 
average, more vegetables (3.8± 2 cups) compared to the recommendations (2.5 cups). 
They also consumed 1.5± 1 cups of fruits and juices compared to a recommended 2 cups. 
Saturated fat intake was measured at a mean of 22± 9.10 g. 
A Stepwise multiple linear regression was used to develop a model for the 
diabetes knowledge score based on demographic and clinical variables was used. The 
model formula is below: 
MDKT score =72.3747*intercept-0.1214*total calories-0.0506*income 
+30.8564*diabetes+ 17.1742*gender-0.2447*age-1.0365*bmi+3.69707*fat 
calories+0.72651*carbohydrates colories-0.33111*saturated fat. 
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The results from the stepwise multiple linear regression model which did not 
include the CU4Health clinical variables are shown in Table 3.9. There were 46 
participants who were included in the full model. In a multivariate statistical (Table 10.9) 
analysis it was shown that total calories (P = 0.0066), having diabetes (P = 0.0013), 
gender (P = 0.0457), BMI (P = 0.0394), calories from fat (P = 0.0341), calories from 
carbohydrates (P = 0.0018), were factors affecting diabetes knowledge score.  
Insignificant factors in the model were income (P = 0.9801), age (P = 0.2863) and 
education (P = 0.0793).  Having diabetes was a significant factor (P = 0.0013), while 
educational attainment was not (P = 0.0793). This meant that, for this group, people with 
diabetes had better diabetes knowledge regardless of their educational attaimen .  
In a second model (Table 3.10) which included the clinical variables, hemoglobin 
(P = 0.0004) and triglycerides (P = 0.0004) were important predictors of diabetes 
knowledge. Other significant variable in the model were income (P = 0.0354), having 
diabetes (P = 0.0021), education (P = 0.0250) and calories from carbohydrates (P = 
0.0007). The formula for the second model is shown below:  
MDKT score = -16.064*intercept+1.6281*income+14.4343*diabetes 
+0.35468*bmi-2.1924*education+0.05366*carbohydrates calories 
+7.04135*hemoglobin+0.03519*triglycerides-12.40535*diabetes2. 
A comparison was made for the 25 participants who allowed access to their 
clinical CU4Health values and some of the values they reported in this study (Table 3.7). 
The longest time that any one participant had stayed in the program was 10 years and the 
mean was 6.88± 3.04 (P <0.0001). The mean change in BMI was -0.58 (P<0.41) while 
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the mean change in weight was -0.59 (P = 0.8680). The mean change in fasting glucose 
was -4.01 (P = 0.3083). 
Discussion 
The CU4Health program provided an ideal group of candidates for this study. The 
program participants are a self-selected group of individuals who have shown an interest 
in seeking health information and education. The information given to them from the 
blood profile tests and various scores on health and wellness provided yet another reason 
for the individuals to improve their health. The nutritional score and counseling given to 
the program participants provided some knowledge of healthy eating habits and 
encouraged the individuals to seek more information in any areas that were problematic 
for them. 
In their health literacy study for diabetes patients, Powel and colleagues found 
that there was a significant association between the level of literacy and the high score in 
their program (P = 0.02) (25). In the present study there was no significant difference 
detected among the education groups (P = 0.4921). Contrary to this study, Powell found 
that there was a significant difference between high literacy patients and those with low 
literacy and those with low literacy missed 13% to 18% of the questions. In this study 
however, all the participants were of arguably high literacy level, making th s difference 
hard to measure. It could be said that the CU4Health program has produced positive
results because of the lack of significant difference between diabetes knowledge observ d 
among educational levels. CU4Health participants who did not have a college degre id 
not score significantly different compared to those who had college degrees. This could 
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mean that the information received through the CU4Health program may have reduc d 
the potential difference in diabetes knowledge score for CU4health participants. In a 
large sample size study, Fitzegerald and colleges found that the Diabetes Knowledge Test 
score increased with the level of education (21). This was also the case in this study; 
however, the difference was not significant. The DKT means ±SD for diffeent ducation 
levels in this study were 74.1±15.8, 75.81±14.1 and 79.46±15.8 for those who do not 
have a college degree, those with a college degree, and those with a graduate degree 
respectively.    
In 2001, Groth and colleagues reported that educational attainment was an 
important factor in explaining the difference in healthy dietary habits between low and 
higher education groups in Denmark (26). There was also a similar finding in a Canadian 
study where high education participants were more likely to follow a meal plan (27) This 
was not the case in our MDKQ results, as only 55% of the participants correctly 
answered a question on types of food that were high on fat (question 4). It is rather 
troubling that such a high percentage of people, who were mostly well educated, did not 
understand variations in fat content among various food products. It is well known that 
consuming a diet that is high in saturated fat and low in vegetables, fruits and whole 
grains increases the chance of weight gain and the development of metabolic chronic 
disorders. The reported food intake results from this study were encouraging, for example 
participants reported a high intake of vegetables. However, the clinical data suggests that 
this group needed to improve its diet. The average cholesterol levels were: total 
cholesterol, 201±42.5 mg/dl; LDL cholesterol, 121.5±37.34 mg/dl; and HDL cholesterol, 
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57±15.24 mg/dl; with mean triglycerides 138±162.98mg/dl. Desirable cholesterol 
numbers are ≤200 mg/dl for total cholesterol, ≤100 mg/dl for LDL and ≥60 mg/dl for 
HDL. Desirable triglycerides levels are ≤150 mg/dl. Subject lipid levels were less than 
optimal and indicate that the CU4Health participants need to reduce their saturated fat 
intake. This can be achieved by choosing their fats wisely and increasing the r 
consumption of whole grains and high fiber foods. 
Some of the CU4Health program participants had already developed diabetes or 
other chronic metabolic disorder as indicated in Table 3.1. With this in mind, this study 
tested the diabetes and nutritional knowledge of the CU4Health program participants. 
Participants with diabetes had better diabetes knowledge, regardless of educational 
attainment. 
The CU4Health program can best address health concerns of its participants if the 
participants are familiar with diabetes education information. It has been shown that a 
lifestyle that reduces the risk of developing diabetes is likely to reduce the risk of 
developing other metabolic disorders, particularly stroke and CVD (most people with 
diabetes die from stroke and CVD).  Therefore, it was encouraging to find that there was 
no significant difference between the college-educated group and those without a college 
education in this study.  
It was anticipated that an online study would increase participation of university 
employees; however, this was not the case (participation rate was 7% of 760 emails sent). 
It may be advisable to re-evaluate the recruitment method to increase participation. The 
majority of the participants (~80%) were female; as a result there may be  need to 
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conduct focus groups to gain more information on increasing male participation.  
Conducting the study online did have the benefit of cost reduction and increased ease of 
obtaining data.  
Conclusions 
In the CU4Health participants, no significant difference in diabetes knowledge 
was observed between those with less than a college degree and those with a college 
degree. No difference in reported amount of calories consumed/group was seen. The 
factors, total calories (P = 0.0066), having diabetes (P = 0.0013), BMI (P = 0.0394), that 
were found to be useful in predicting diabetes knowledge could be used when 
constructing lifestyle interventions. The study findings indicated that the partici nts 
consumed less than recommended servings of whole grain and dairy products.  An 
intervention that encourages the consumption of aforementioned products would be ideal 
for the study participants. Participants had high diabetes knowledge but most did not 
know much about the A1c test. An intervention that has an educational component 
providing the latest information about diabetes and other chronic metabolic disorders 
would increase their knowledge.  The findings of this study enhance the understanding of 
the eating habits and health conditions and diabetes knowledge of the CU4Health 
participants. Information obtained from the current study can be used to design future 
worksite interventions for diabetes, and other related chronic diseases, for CU4Health 
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Table 3.1: Study Population Demographic Characteristics 
Variable 
 
Values Number Percentage 
 







































BMI1, kg/m2 Normal (18.5-24.9) 
Overweight (25-29.9) 



















Education Completed High School 
Some College 
Bachelor degree 












Employment Full Time 














$80,000 – 89,000 


































4 6 14% 

































> 150,000   
> 50,000 <150,000  
















high blood glucose levels 
high blood pressure 
high cholesterol values 













   1BMI values derived from self reported height and weight values. 



































































Level of Education Some High School 
High School Graduate 
Some College 






































































































































(n = 3978) 
Not Indicated 
Some High School 
High School Graduate 
Some College 














*The percentages were rounded to the nearest 10th and total of 99.99                                                                                   
#Additional data provided by Dr. Ronald Chrestman, Office of Institutional Research, 














Table 3.4. Subject Demographic Information from the Current Study, Clemson 




































































































Table 3.5: Characteristics of CU4Health Participants by Educational Categories 
 
                                                 No College                           With College                            
Item N Means±SD N Means±SD p-value 
MDKT Score 17 74.78±15.79 27 78.56±15.24 <0.611 
Total Calories (kcal) 14 1882.8±595.10 23 1724.8±465 <0.378 
Income1 16 2.06±0.92 25 3.11±1.21 <0.003 
Age (yrs) 14 53.57±.17 25 51.76±10.06 <0.650 
Gender* (M/F) 14 1.94±0.24 25 1.72±0.45 <0.045 
BMI (kg/m2) 14 29.80±6.46 25 25.5±4.17 <0.431 
Fat Calories (kcal) 14 712.17±25 23 625.32±224 <0.324 
Carbohydrate 
Calories (kcal) 
14 881.52±32 23 807.56±242 <0.440 
Saturated Fat Calories 
(kcal) 
14 224.64±83.60 23 185.22±79.1 <0.205 
      1. Income categories: 1 = $20,000 – 29,000, 2 = 30,000 – 39,000, 3 = 40,000 – 49,000, 
 4 = 50,000– 59,000 
      *Gender: 1 = Male, 2 = Female 
 
 
Table 3.6 Comparison of Foods Consumed by Subjects with the Recommended 
















2. Means ±SD 




Item Means Intake Per Day1,2 Recommended3 
Vegetables 3.8± 2cups 2.5 cups 
Fruits & fruit juices 1.5±1 cups 2 cups 
Breads, cereals, rice, 
pasta 
4.6±2.2 oz 10 oz 
Meat, fish, poultry, 
beans, eggs 
2.2±1.1 oz 5.5 oz 
Milk, yogurt, cheese 1.3±0.8 cups 3 cups 
Fats & oils, sweets, 
sodas 
3.0±1.1 tsp 6 tsp 
Whole grains 0.6± 0.8oz 6 oz 
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                 *The characteristics above were not significant at the 0.05 levels of significance.  
                 1. Values are expressed as means ± standard deviation 
                 2. Hgb – Hemoglobin 
                 3. Cholesterol – Total Cholesterol 
                 4. TAG – Triglycerides 


















Mean 12.8±1.0 218±36.6 131.7± 32 59.7±16.2 131.3± 87.392.4± 19.6 27.2± 7.7 
        
With 
degree 
Hgb Cholesterol LDL HDL TAG Glucose BMI 




Table 3.8. Correlated Valuables from the Full Research Data 
 
Variables P-Value R 
Score and  Age <0.0092 -0.32 
Score  and  Being  married  <0.0094 -0.31 
Score and Income  <0.0225 0.37 
Education and Gender  <0.0203 -0.34 
Education and BMI  <0.0372 -0.30 
Education and Income  <0.0278 0.33 
Total calories and BMI  <0.0106 0.40 
Total calories and age  <0.0092 -0.40 
               P-Value: 0.05 levels of significance 
               r- Is the correlation coefficient 
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Overall P-value 0.0102 


















Overall P-value 0.001 







Variable Coefficient P-value 
Constant 72.3747 <0.0082 
Total calories -0.1214 <0.0066 
Income -0.0506 <0.9801 
Diabetes 30.8564 <0.0013 
Gender 17.1742 <0.0457 
Age -0.2447 <0.2863 
BMI -1.0365 <0.0394 
Education 3.6970 <0.0793 
Fat calories 1.0760 <0.0341 
Carbohydrates Calories 0.7265 <0.0018 
Saturated fat -0.3311 <0.7124 
Variable Coefficient P-value 
Constant -16.0640 <0.3361 
Income 1.6281 <0.0354 
Diabetes 14.4343 <0.0021 
BMI 0.35468 <0.0819 
Education -2.1924 <0.0250 
Carbohydrates Calories 0.05366 <0.0007 
Hemoglobin 7.04135 <0.0004 
Triglycerides 0.03519 <0.0004 




























Study Website Page 
  
Welcome to the 
"Evaluation of Health, Diabetes Knowledge & Behaviors of CU4Health Participants 
at Clemson University" 
 
You are invited to participate in a research study 
conducted by Vivian Haley-Zitlin, Ph.D., R.D., L.D., 
and Peter Mukwevho from the Department of Food 
Science and Human Nutrition. 
The purpose of this research is to assess health and 
diabetes knowledge and behavior of employees at 
Clemson University who have shown interest in their 
health status by their participation in the CU4Health 
program. The results from this study will be used to 
design a comprehensive nutrition and health intervention for Clemson University 
employees participating in CU4Health 
  
In this website you will find the following: 
• You will be able to download and print a consent form 
• The Michigan Diabetes Knowledge Test 
• A Demographic Questionnaire 
• The Block Food Frequency Questionnaire 
Please note that each link will open in a new window 
Please review the IRB approved consent form (pdf format) 




• Click here for the Diabetes Knowledge Test 
• Click here for the Demographic Questionnaire 
• Click here for the Food Frequency Questionnaire 
Upon completion of consent forms participants will receive a packet of educational 
materials which will include fact sheets and health related websites. Additional items 
may include measuring cups, etc. Participants' names will be included in random 
drawings for giveaways. 
If you have any questions regarding this research, please contact me at the following 
location: 
Peter Mukwevho 
Department of Food Science and Human Nutrition 





















Demographic Questionnaire  
 
Created: June 30 2009, 8:11 AM 
Last Modified: June 30 2009, 8:11 AM 
Design Theme: Basic Blue 
Language: English 
Button Options: Labels 
Disable Browser “Back” Button: False 
 
Page 1 - Question 1 - Open Ended - One Line 
Name: please enter your name 
Page 1 - Question 2 - Choice - Multiple Answers (Bullets) 
What is your age group? 
 18-19 years old 
 20-29 years old 
 30-39 years old 
 40-49 years old 
 50-59 years old 
 60-69 years old 
 70-79 years old 
 80 years old and over 
 
Page 1 - Question 3 - Choice - Multiple Answers (Bullets) 




Page 1 - Question 4 - Choice - Multiple Answers (Bullets) 





 Native American 
 Other, please specify 
Page 1 - Question 5 - Open Ended - One Line 
What is your height? 
 
Page 1 - Question 6 - Open Ended - One Line 




Page 1 - Question 7 - Choice - Multiple Answers (Bullets) 
Do you smoke cigarettes? 
 No 
 Yes 
 How many cigarettes do you smoke each day? 
 
 
Page 1 - Question 8 - Choice - Multiple Answers (Bullets) 
What is your marital status?  (please check  one) 
 Married 




Page 1 - Question 9 - Choice - Multiple Answers (Bullets) 
What is your highest education level completed?  (please check one 
 Completed college (4 year Bachelor degree) 
 Completed Graduate or Professional School 
 Completed High School/GED 
 Currently attending college (4 year Bachelor degree) 
 Currently attending Graduate School (Masters, Ph.D., M.D., etc.) 
 Less than 12th grade 
 Some College or Vocational School Training 
 
Page 1 - Question 10 - Choice - Multiple Answers (Bullets) 
Please check the one(s) which apply to you 
 Employed full-time 
 Employed part-time 
 Not employed 
 
Page 1 - Question 11 - Choice - Multiple Answers (Bullets) 
What is the approximate level of your household income before taxes? (please check one) 
 $10,000 – 19,000 
 $100,000 and above 
 $20,000 – 29,000 
 $30,000 – 39,000 
 $40,000 – 49,000 
 $50,000 – 59,000 
 $60,000 – 69,000 
 $70,000 – 79,000 
 $80,000 – 89,000 
 $90,000 – 99,000 
 Under $10 000 
 
Page 1 - Question 12 - Open Ended - One Line 




Page 1 - Question 13 - Open Ended - One Line 
 
Number of people in household under 18 years of 
Page 1 - Question 14 - Open Ended - One Line 
Number of people in household over 65 years of age 
Page 1 - Question 15 - Choice - Multiple Answers (Bullets) 
Place of residence 
 City of 2000,000 – 400,000 people 
 City over 400,000 (example: Greenville, SC) 
 City with over 100,000 people 
 City with over 150,000 people (example: Anderson, SC) 
 Farm 
 Suburb of city with over 50,000 people 
 Town of less than 10,000 people or rural non-farm (example: Pendleton, SC; Easley, SC) 
 Town or city with 10,000 to 50,000 people or their suburb (example: Clemson, SC; 
Seneca, SC) 
 
Page 1 - Question 16 - Choice - Multiple Answers (Bullets)  
County residence 
 Anderson county 
 Greenville county 
 Oconee county 
 Pickens county 
 Spartanburg county 
 Other, please specify 
 
 
Page 1 - Question 17 - Choice - Multiple Answers (Bullets) 
Have you been diagnosed with any of the following by your health care provider?  Please check 
all that apply 
 cardiovascular disease 
 diabetes 
 high blood glucose levels 
 high blood pressure 
 high cholesterol values 










Diabetes Knowledge Test 
 
Michigan Diabetes Knowledge Test 
 
Created: June 30 2009, 1:53 PM 
Last Modified: June 30 2009, 1:53 PM 
Design Theme: Basic Blue 
Language: English 
Button Options: Labels 
Disable Browser “Back” Button: False 
 
 
Diabetes Knowledge Test 
 
Page 1 - Question 1 - Open Ended - One Line 
What is your name? (Please write your first and last name 
Page 1 - Question 2 - Choice - Multiple Answers (Bullets) 
The diabetes diet is: 
 a healthy diet for most people 
 the way most American people eat 
 too high in carbohydrate for most people 
 too high in protein for most people 
 
Page 1 - Question 3 - Choice - Multiple Answers (Bullets) 
Which of the following is highest in carbohydrate? 
 Baked chicken 
 Baked potato 
 Peanut butter 
 Swiss cheese 
 
Page 1 - Question 4 - Choice - Multiple Answers (Bullets) 
Which of the following is highest in fat? 
 Corn 
 Honey 
 Low fat milk 
 Orange juice 
Page 1 - Question 5 - Choice - Multiple Answers (Bullets) 
Which of the following is a “free food”? 
 Any dietetic food 
 Any food that has less than 20 calories per serving 
 Any food that says “sugar free” on the label 
 Any unsweetened food 
 
Page 1 - Question 6 - Choice - Multiple Answers (Bullets) 
Glycosylated hemoglobin (hemoglobin A1) is a test that is a measure of your average blood 
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glucose level for the past 
 6 months 




Page 1 - Question 7 - Choice - Multiple Answers (Bullets) 
Which is the best method for testing blood glucose? 
 Blood testing 
 Both are equally good 
 Urine testing 
 
Page 1 - Question 8 - Choice - Multiple Answers (Bullets) 
What effect does unsweetened fruit juice have on blood glucose 
 Has no effect 
 Lowers it 
 Raises it 
 
Page 1 - Question 9 - Choice - Multiple Answers (Bullets) 
Which should not be used to treat low blood glucose? 
 1 cup diet soft drink 
 1 cup skim milk 
 1/2 cup orange juice 
 3 hard candies 
 
Page 1 - Question 10 - Choice - Multiple Answers (Bullets) 
For a person in good control, what effect does exercise have on blood glucose? 
 Has no effect 
 Lowers it 
 Raises it 
 
Page 1 - Question 11 - Choice - Multiple Answers (Bullets) 
Infection is likely to cause 
 a decrease in blood glucose 
 an increase in blood glucose 
 no change in blood glucose 
 
Page 1 - Question 12 - Choice - Multiple Answers (Bullets) 
The best way to take care of your feet is to 
 buy shoes a size larger than usual 
 look at and wash them each day 
 massage them with alcohol each day 
 soak them for one hour each day 
 
Page 1 - Question 13 - Choice - Multiple Answers (Bullets) 
Eating foods lower in fat decreases your risk for 
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 eye disease 
 heart disease 
 kidney disease 
 nerve disease 
 
Page 1 - Question 14 - Choice - Multiple Answers (Bullets) 
Numbness and tingling may be symptoms of 
 eye disease 
 kidney disease 
 liver disease 
 nerve disease 
 
Page 1 - Question 15 - Choice - Multiple Answers (Bullets) 
 
Which of the following is usually not associated with diabetes 
 kidney problems 
 lung problems 
 nerve problems 



















Consent Form for Research Study 
Consent Form for Participation in a Research Study 
Clemson University 
 
Evaluation of Health, Diabetes Knowledge and Behaviors of CU4Health 
Participants at Clemson University. 
 
Description of the research and your participation 
 
A. You are invited to participate in a research study conducted by Dr. Vivian Haley-
Zitlin and Peter Mukwevho. The purpose of this research is to assess health and 
diabetes knowledge and behavior of employees at Clemson University, who have 
shown interest in their health status by their participation in the CU4Health program. 
The results from this study will be used to design a comprehensive nutrition and 
health intervention for Clemson University employees participating in CU4Health. 
 
B. There are 2 options for participation: 
1. You may choose to participate by completing the questionnaires and 
granting us access to your CU4Health data.  
Or 
2. You may choose to participate by completing the questionnaires only.  
 
 Participation details are:  
a) Assessment of your health and diabetes knowledge by completing a food 
intake and diabetes knowledge questionnaire and demographic 
information.  
b) Granting access to your CU4Health program data which will include your 
health and diet history along with your height, weight, BMI, blood 
pressure, Blood Lipid Profile (cholesterol values and triglycerides), and 
Blood Chemistry Profile  including blood glucose (blood sugar) and 
electrolytes as well as your demographic information. 
 
The amount of time required to complete the online questionnaires will be approximately 
35-60 minutes. Assessing your CU4Health program data will require no additional time 
from you. 
 
Risks and discomforts 
 
No identifiable risk is expected to occur to participants from participang in this study; however, 
there is always a risk of electronically transferred data being illegally intercepted. The benefits 
to the participants will outweigh the risks, as the information obtained will be used to 
113 
 
help develop a program for CU4Health participants to delay or prevent the development 




The information obtained from the questionnaires will be used to assess the health habits 
of Clemson University employees who have participated in the CU4Health Wellness 
Program. The information acquired may be used to recommend specific changes that will 
be beneficial to the CU4Health participants. Information gained will used to design a 
nutrition and health intervention for Clemson University employees. The information that 
is obtained from this study may be used scientifically and may be helpful to others. 
 
Protection of confidentiality 
 
The records of your participation will be kept confidential. The investigator will maintain 
your information, from your participation in this study and the information to be obtained 
from the CU4Health data, in a locked cabinet and on a password-protected computer. 
Your name will be used to link your questionnaire responses with your CU4Health 
information. Your name and the data acquired from the questionnaires will be shared 
with the Sullivan Center. Individuals will not be identified in publications arising from 
this study.  
 
In rare cases, a research study will be evaluated by an oversight agency, such as the 
Clemson University Institutional Review Board or the federal Office for Human 
Research Protections that would require that we share the information we collect fr m 
you. If this happens, the information would only be used to determine if we conducted 




Your participation in this research study is voluntary. You may choose not to participate 
and you may withdraw your consent to participate at any time. You will not be penalized 
in any way should you decide not to participate or to withdraw from this study. It is 




If you have any questions or concerns about this study or if any problems arise, plea 
contact Vivian Haley-Zitlin, Ph.D., R.D., L.D. at Clemson University phone number, 
864-656-7716. You are encouraged to ask questions you may have during the course of 
this study.  If you have any questions or concerns about your rights as a research 






C. Please check the box below to indicate your preferred level of participation. 
If you would like to grant us access to your CU4Health data please sign and send in / 
drop off the signed consent forms back to us.  
           
                     I wish to participate fully (questionnaires + CU4Health) 
                     I wish to complete the questionnaires only 
 
If you have any questions or concerns please contact Peter or Vivian prior to 
submitting your consent form or check the boxes below 
  
                      Please contact me for informed consent questions 




I have read this consent form and have been given the opportunity to ask questions. 
I give my consent to participate in this study. 
 
Name (please print):  __________________________________ 
 
Participant’s signature: ________________________________   Date:  ______________ 
 
Please submit your consent form by interoffice mail by  (date)  to: 
 
Dr. Vivian Haley-Zitlin 
Food Science and Human Nutrition Department 
211 Poole Agricultural Center 
Clemson University 




Contact Peter Mukwevho at (864) 656-5693 for a consent form delivery or pick-up.  
 
 
 
 
 
 
 
 
 
 
 
 
 
